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Figure 1.1 - ASM Contraction - ASM contraction is stimulated by the activation of 
signaling cascades downstream of G-protein coupled receptors that ultimately lead to 
the phosphorylation of myosin light chain.  In addition, calcium independent signaling 
mechanisms that act via a RhoA mediated pathway are able to increase the 
contractility of ASM by inhibiting the function of myosin light chain phosphatase.  
[Figure adapted from (Chiba 2004)]. !
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Figure 2.1 - Representative RNA sample - RNA was harvested using TRIzol 
methodology and DNase treated.  The image is an electropherogram representation of 
an RNA sample as produced by the Agilent Bioanalyser Software. The arrows 
correspond to A) 5S RNA including miRNAs, B) 18S RNA and C) 28s RNA.  The 
RNA Integrity Number of this sample, as determined by the Agilent software, was 
8.0.  !
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B@F@D!Z0*#'('*'($%!H<I!XUH<IY!2+1!-*'01%!-(IJ7&!>/&:.)#*2!D/7/!2/.!,;!D).8!&!6)*&4!:#*:/*.7&.)#*!#6!IT!"&S$&*!2;/:)6):!;7)$/7!M2//!"&-4/! ))NA! IT! $&2./7! $)T! M?;;4)/(! X)#2<2./$2N! &*(! Lµ4! :9U?! ./$;4&./! '/*/7&./(!67#$!.8/!:#77/2;#*()*'!7/O/72/!.7&*2:7);.)#*!7/&:.)#*!M2//!38&;./7!LP[PLNP!!S%3>!D&2!;/76#7$/(!,2)*'!:<:4)*'!;&7&$/./72!#6!&*!)*).)&4!)*:,-&.)#*!&.!Bc°:!6#7!L!$)*,./2!&*(!JB°:!6#7!Ic!$)*,./2A!6#44#D/(!-<!_c!:<:4/2!#6!JB°:!6#7!IB!2/:#*(2!&*(!`c°:!6#7!I!$)*,./!,2)*'!&*!?XY!%7)2$!aJcc`X! #7! 4/.Va-! &2! .8/! /*(#'/*#,2! :#*.7#4! '/*/A! 2.&./(! )*! .8/! 7/2,4.2! D8/7/!&;;7#;7)&./P! ! "8/! /T;7/22)#*! 4/O/4! #6! 2;/:)6):!$)>U?2!D&2! :&4:,4&./(! &::#7()*'! .#!
''3.! $/.8#(#4#'<A! /T;7/22/(! &2! '3.! v! 3..&7'/.! i! 3.:#*.7#4! &*(! ''3.! v! LVM'3."&7'/.e'3.>/6/7/*:/NP!
!
-(IJ7! H1(-%1!"O!J0-8%1!>U@`X! ccIcJ[!$)>VLc&! cccBbc!$)>VJ[! ccc_[L!$)>VI_`&! ccc_`b!$)>VIBB! ccc_aJ!$)>V[[B! cccB_`!5/.Va-! ccL`IJ!
!
Table ii – miRNA RT and qPCR primer setsV! ?44! ;7)$/72! D/7/! 67#$! ?;;4)/(!X)#2<2./$2P!
!
B@F@L!UH<I!'+!:%'%1-(#%!-IJ7!%341%&&(+#!%7)$/7!2/.2!.#!&22/22!.8/!/T;7/22)#*!#6!$>U?2!-<!S%3>!D/7/!/).8/7!"&S$&*!F/*/!HT;7/22)#*! ?22&<2! M?;;4)/(! X)#2<2./$2N! #7! (/2)'*/(! ,2)*'! .8/! @*)O/72&4! %7#-/!
! _`!
5)-7&7<!M@%5A!>#:8/N!)*!:#$-)*&.)#*!D).8!2;/:)6):!64&*K)*'!;7)$/72!MH,7#6)*2!=EFN!M6#7!(/.&)42A! 2//!"&-4/! )))NP! ! Ib
 
Gene Taqman / UPL Primer Number UPL Flanking oligos (5'-3') 
BIC Taqman  hs01374570_m1 N/A N/A 
RhoA UPL N/A 9 ctcggattcgttgcctga 
        ggaactggtccttgctgaag 
MYLK UPL N/A 15 tgcttcagaatgaggacgtg 
        acacctggcaactgcattc 
CCL2 UPL N/A 4 agtctctgccgcccttct 
        gtgactggggcattgattg 
CCL5 UPL N/A 3 acaccagtggcaagtgctc 
        acacacttggcggttctttc 
CCL11 UPL N/A 40 atgaaggtctccgcagca 
        ggtggttgggacagaagc 
CCL13 UPL N/A 40 accttcaacatgaaagtctctgc 
        ggacgttgagtgcatctgg 
CCL26 UPL N/A 38 cctgagtctccaccttggaa 
        aaggggcttgtggctgta 
CD38 Taqman hs00277045_m1 N/A N/A 
CXCL10 Taqman hs00171042_m1 N/A N/A 
CXCL11 Taqman hs00171138_m1 N/A N/A 
IRF1 Taqman hs00971960_m1 N/A N/A 
BRWD1 UPL N/A 4 ccacccagtatttcaagagtca 
        ctgtgtgcctgcagtctttt 
COL21A1 UPL N/A 7 ttaatgggtagtcccggtttc 
        ctccccgtgttccatcct 
MALAT1 UPL N/A 10 gcaggtgctagttcttggagtt 
        gctcctgacaaattatacatcaagg 
ITGA8 UPL N/A 3 tggctccagcttcctatgat 
        tgctgagaatccccagtaaac 
ZNF652 UPL N/A 28 ttcgacgaacacatgaaaaca 
        gtgagttctgcggtgtctctt 
!
Table iii  - Details of primers used for qPCR studies  
!




B@D@=!H1+'%(#!%3'1*/'(+#!C#44#D)*'!.8/!.7&*26/:.)#*!#6!?+=32!D).8!;7/!#7!&*.)V$)>U?2!M(/2:7)-/(!)*!38&;./7!LPLPINA! :<.#;4&2$):! &*(! *,:4/&7! ;7#./)*! 67&:.)#*2! D/7/! )2#4&./(! 67#$! ITIc`! :/442!,2)*'!&!UHV%H>!K).!M"8/7$#!+:)/*.)6):N!&::#7()*'!.#!.8/!$&*,6&:.,7/72!)*2.7,:.)#*2P!!HT.7&:.2! D/7/! S,&*.).&./(! ,2)*'! &! X3?! &22&<! M%)/7:/N! .#! /*2,7/! .8&.! :#$;&7&-4/!&$#,*.2!#6!.#.&4!;7#./)*!D/7/!,2/(!)*!2,-2/S,/*.!&*&4<2/2P!!
B@D@B!KOK>4+.6*/16.*-(:%!)%.!%.%/'1+4,+1%&(&!*#:!5%&'%1#!8.+''(#)!%#4<&:7<4&$)(/!'/42!D/7/! :&2.! &.!bk!#7!IBk! 6#7! )*./77#'&.)#*!#6!>8#?!&*(!=f50!;7#./)*!/T;7/22)#*!7/2;/:.)O/4<P!![Bw'!#6!:<.#2#4):!;7#./)*!/T.7&:.A!&2!(/./7$)*/(!-<!X3?!&22&<A!D&2!(/*&.,7/(!-<!.8/!&(().)#*!#6!2#(),$!(#(/:<4!2,46&./!M+9+N! 4#&()*'!-,66/7! M`LPB$=!"7)2!G34! x;G`PbyA! Lk! +9+A! Bk! '4<:/7#4A! cP[=!!LV$/7:&;.#/.8&*#4!&*(!cPcIk!-7#$#;8/*#4!-4,/N!&*(!)*:,-&.)#*!&.!JB°:!6#7!B!$)*,./2P!!%7#./)*2!D/7/!2/;&7&./(! -<! /4/:.7#;8#7/2)2! .87#,'8! .8/! ;#4<&:7<4&$)(/! '/4! )*! IT! 7,**)*'! -,66/7!MLPB$=!"7)2A! LB$=!F4<:)*/! x;GbP[y! &*(!cPcIk!+9+N! &.! LB$?$;2e'/4P! ! C#44#D)*'!.8/! 2,66):)/*.! 7/2#4,.)#*! #6! ;7#./)*2! &.! .8/! 7/S,)7/(! 2)R/A! .8/! ;7#./)*2! D/7/!.7&*26/77/(!.#!&!*).7#:/44,4#2/!$/$-7&*/!M?$/728&$N!-<!/4/:.7#;8#7/.):!.7&*26/7!)*!IT! .7&*26/7! -,66/7! MLB$=! "7)2! G34A! IJL$=! '4<:)*/! &*(! Ick! $/.8&*#4N! &.!_cc$?$;2!6#7!Jc!$)*,./2P!!"#!;7#-/!6#7!>8#?!;7#./)*A!$/$-7&*/2!D/7/!)*).)&44<!-4#:K/(!D).8!Bk!$)4K!)*!"X+V"D//*!6#7!I!8#,7!&.!7##$!./$;/7&.,7/P!!=/$-7&*/2!D/7/!;7#-/(!D).8!&*!&*.)V>8#?!&*.)-#(<!MIubccA!?-:&$A!&-B_b[BN!)*!Bk!$)4K!)*!"X+V"D//*!#O/7*)'8.!&.!_°:!D).8!7#:K)*'A!-/6#7/! .87//!D&28/2!D).8!"X+V"D//*P! !"8/!$/$-7&*/2!D/7/! .8/*!-7)/64<!7/V-4#:K/(!D).8!Bk!$)4K!)*!"X+V"D//*!6#7![c!$)*,./2!&.!7##$!./$;/7&.,7/A!-/6#7/!&*! &*.)V$#,2/VG>%! 2/:#*(&7<! &*.)-#(<!D&2! &((/(! MIuIcccA! +&*.&! 37,RA! 2:VLcBBNP!!"8/!$/$-7&*/2!D/7/!(/O/4#;/(!D).8!H35!M?$/728&$N!&*(! .8/! )$&'/!/T;#2/(!#*!G)'8!+/*2).)O).<!G<;/76)4$!M?$/728&$NP!!"8/!$/$-7&*/2!D/7/!.8/*!2.7);;/(!-<!&!I!8#,7! )*:,-&.)#*!&.!Bc°:!D).8!IT!2.7);;)*'!-,66/7!MIcc$=!!LV$/7:&;.#/.8&*#4A!Lk!+9+! &*(! `LPB*=! "7)2! G35! x;G`PbyN! &*(! 7/V;7#-/(! D).8! &*! &*.)VF?%9G! &*.)-#(<!MIuLBcccA! F/*/"/TA! F"rLbL_BN! &*(! &*.)V$#,2/VG>%! 2/:#*(&7<! &*.)-#(<! M&2!-/6#7/NA!&2!&!4#&()*'!:#*.7#4P!
! _b!
%7#-)*'!6#7!=f50!D&2!:&77)/(!#,.!&2!6#7!>8#?A!/T:/;.!.8&.!-4#:K)*'!D&2!;/76#7$/(!)*! Bk! -#O)*/! 2/7,$! &4-,$)*! )*! "X+V"D//*P! ! ?*.)-#()/2! ,2/(! D/7/! &*.)V=f50!MIu_cccA!?-:&$A!H%I_BbfN!&*(!&*.)V7&--).VG>%!2/:#*(&7<!MIuLBccA!+&*.&!37,RA!2:VLcc_NP!!"8/!S,&*.)6):&.)#*!#6!D/2./7*!-4#.2!D&2!;/76#7$/(!-<!(/*2).#$/.7<!&*&4<2)2!,2)*'!Y$&'/d,&*.!2#6.D&7/P!!"8/!)*./*2).<!#6!/&:8!-&*(!D&2!:&4:,4&./(!&*(!*#7$&4)2/(!.#!.8/! -&:K'7#,*(! )*./*2).<! #6! ;)T/42! )$$/()&./4<! &(Q&:/*.! .#! .8/! $&7K/(! &7/&!:#*.&)*)*'! &!-&*(P! ! Y*./*2).)/2!#6!>8#?!-&*(2!D/7/!*#7$&4)2/(! .#!F?%9G!&*(!&7/!/T;7/22/(!7/4&.)O/!.#!.8/!*#*V.7&*26/:./(!$#:K!2&$;4/P!!
B@D@F!<<QL!RQ"K7!+,;/7*&.&*.2!67#$!.7&*26/:./(!?+=32!M(/2:7)-/(!)*!38&;./7!LPLPIN!D/7/!2.#7/(!&.!VLc°:P! ! ?*!H5Y+?! .#! (/./7$)*/! .8/! 4/O/42! #6! 335B! )*! .8/! 2,;/7*&.&*.2! #6! 7/2;/:.)O/!;#2.V.7&*26/:.)#*!:,4.,7/2!D&2!;/76#7$/(!,2)*'!&!G,$&*!335Be>?U"H+!d,&*.K)*/!H5Y+?!K).!M>n9!+<2./$2N!&::#7()*'!.#!.8/!$&*,6&:.,7/72!)*2.7,:.)#*2P!!
B@L!<.+#(#)!*#:!'%&'(#)!4+'%#'(*.!-(I>=LL!'*1)%'!&('%&!;F5_PI[!&*(!;>5V"0!;4&2$)(2!M%7#$/'&A!2//!C)',7/!LPLN!D/7/!&!')6.!67#$!97!+,2&*!^#8*!M035A!5#*(#*A!@0NP!
!%7)$/72! D/7/! (/2)'*/(! .#! &$;4)6<! 7/')#*2! #6! [ccVBcc! -&2/! ;&)72! :/*./7)*'! #*!;7/():./(!$)>VIBB!.&7'/.!2)./2P!!%3>!7/&:.)#*2!D/7/!;/76#7$/(!6#7!)*()O)(,&4!.&7'/.2!,2)*'! .8/! ;7)$/72! (/.&)4/(! )*! "&-4/! )O! .#! &$;4)6<! 7/')#*2! 67#$! ./$;4&./! 9U?! #6!/).8/7!:9U?!)2#4&./(!67#$!8/&4.8<!8,$&*!?+=32!#7!.#.&4!'/*#$):!9U?!M%7#$/'&NP!!%3>! 7/&:.)#*2! D/7/! ;7/;&7/(! &2! B*'! :9U?! #7! IB*'! '/*#$):! 9U?! ./$;4&./! M&2!&;;7#;7)&./A! 2//! "&-4/! )ONA! IT! "&S! X,66/7! MC/7$/*.&2NA! LPB$=!='34L! MC/7$/*.&2NA!LPB$=!(U"%2!MC/7$/*.&2NA!cP_*=!2;/:)6):!64&*K)*'!;7)$/72!M2//!"&-4/!)ON!&*(!cPI@!>/:#$-)*&*.! "&S! ;#4<$/7&2/! MC/7$/*.&2N! &*(! ;/76#7$/(! ,2)*'! .8/! :<:4)*'!;&7&$/./72! #6! JB°:! 6#7! Ic! $)*,./2A! 6#44#D/(! -<! LB! :<:4/2! #6! JB°:A! .8/! 2;/:)6):!&**/&4)*'!./$;/7&.,7/!6#7!&!;7)$/7!;&)7!&*(!aL°:A!6#7!I!$)*,./!/&:8A!6#44#D/(!-<!Ic!$)*,./2! &.! aL°:P! ! ?44! %3>2! D/7/! ;/76#7$/(! ,2)*'! &! =&2./7:<:4/7! F7&()/*.! %3>!$&:8)*/!MH;;/*(#76NP!!"8/!7/2,4.&*.!%3>!2#4,.)#*2!D/7/!/4/:.7#;8#7)2/(A!-/6#7/!.8/!%3>!;7#(,:.!D&2!/T:)2/(!&*(!9U?!;,7)6)/(!67#$!.8/!&'&7#2/!Md)&'/*A!F/4!HT.7&:.)#*!0).NP!!%3>!;7#(,:.2!D/7/!2,-V:4#*/(!()7/:.4<![1!#6!.8/!4,:)6/7&2/!#;/*V7/&()*'!67&$/!MW>CN!)*!.8/!;F5_PI[!;4&2$)(!,2)*'!r-&I!#7!C2/I!7/2.7):.)#*!2)./2!M&2!)*():&./(A!2//!
! _J!
C)',7/!LPL!&*(!"&-4/!)ONP!%3>!)*2/7.2!D/7/!4)'&./(!)*.#!.8/!;F5_PI[!O/:.#7!,2)*'!"_!9U?!4)'&2/!MC/7$/*.&2N!-/6#7/!.7&*26#7$&.)#*!#6!.8/!4)'&.)#*!$)T!)*.#!"W%Ic!:/442A!&::#7()*'! .#! .8/! $&*,6&:.,7/72! )*2.7,:.)#*2! MY*O).7#'/*NP! ! %4&2$)(! 9U?! D&2!;7/;&7/(! 67#$! )*()O)(,&4! :#4#*)/2! -<!=)*);7/;! Md)&'/*NA! r-&I! #7! C2/I! 7/2.7):.)#*!()'/2.!;/76#7$/(!.#!:#*6)7$!.8/!;7/2/*:/!#6!&!:#77/:.4<!2)R/(!)*2/7.!&*(!2/S,/*:)*'!#6! .8/! ;4&2$)(! ;/76#7$/(! .#! /*2,7/! .8/! )*./'7).<! &*(! #7)/*.&.)#*! #6! .8/! )*2/7.P!!=&T);7/;2!D/7/!;/76#7$/(! .#!'/*/7&./!2,66):)/*.!S,&*.).)/2!#6! )*()O)(,&4!;4&2$)(2!Md)&'/*NP!!



























Table iv - Predicted miR-155 target site cloning – Shows the DNA source from 
which each predicted miR-155 target site was cloned along with the sequence of each 
primer used.  The primer sequence in bold type indicates the restriction enzyme digest 
site added to each primer to enable efficient sub-cloning. !
! Bc!
Figure 2.2 – Plasmid maps of pGL4.13 and pRL-TK vectors- pGL4.13 and pRL-
TK vectors were used in Dual-luciferase assays.  The location of the Xba1 and Fse1 
restriction sites in pGL4.13 is shown. !
! BI!
B@L@B!Q0/(2%1*&%!7&&*6&!5,:)6/7&2/!&22&<2!D/7/!;/76#7$/(!,2)*'!.8/!9,&4!5,:)6/7&2/!>/;#7./7!?22&<!+<2./$!&::#7()*'!.#!.8/!$&*,6&:.,7/72!)*2.7,:.)#*2!M%7#$/'&N!6#44#D)*'!.8/!.7&*26/:.)#*!#6!GH0LJ[!:/442!&2!(/2:7)-/(! )*!38&;./7!LPLP[P! !X7)/64<A!$/()&!D&2! 7/$#O/(! 67#$! .8/!GH0LJ[! :/442! &*(! &! %X+!D&28! ;/76#7$/(P! ! 3/442!D/7/! .8/*! 4<2/(! )*! h%&22)O/! 5<2)2!X,66/71!-<!&!IB!$)*,./!)*:,-&.)#*!&.!7##$!./$;/7&.,7/!D).8!7#:K)*'P!!Ic,4!#6!4<2&./!D&2!.&K/*!&*(!&((/(!.#!5?>YY!-,66/7!-/6#7/!4,$)*/2:/*:/!D&2!$/&2,7/(!MX/7.8#4(!G&*(8/4(! 5,$)*#$/./7NP! ! +.#;! n! F4#! 2#4,.)#*! D&2! &((/(! &*(! >/*)44&! 4,:)6/7&2/!$/&2,7/(!&2! &! .7&*26/:.)#*! :#*.7#4P! ! "7);4):&./2!#6! 4,$)*/2:/*:/!D/7/! 7/:#7(/(!&2!./:8*):&4!7/;4):&./2!6#7!/&:8!.7&*26/:.)#*!&*(!&O/7&'/!4,$)*/2:/*:/!:&4:,4&./(P!!9&.&!&7/! ;7/2/*./(! 6#44#D)*'! :#77/:.)#*! 6#7! >/*)44&! 4,:)6/7&2/! 4/O/42! &2! &! :#*.7#4! 6#7!.7&*26/:.)#*!/66):)/*:<!&*(!&7/!/T;7/22/(!7/4&.)O/!.#!:/442! .7&*26/:./(!D).8!;F5_PI[!&*(!;>5V"0!-,.!*#!2$&44!>U?P!!
B@A!C(/1+*11*6&!
B@A@=!7226-%'1(3!?%#%<,(4" !-(IJ7!-(/1+*11*6!
B@A@=@=!T.*&,;*)!S(+'(#!VKI!IJ7!.*8%.(#)!Iµ'! #6! .#.&4! >U?! ;/7! 2&$;4/!D&2! 4&-/4/(! ,2)*'! .8/! F/*)2;8/7/! C4&28"&'"=! X)#.)*!4&-/4)*'!2<2./$!MF/*)2;8/7/A!&2!;/7!$&*,6&:.,7/72! )*2.7,:.)#*2NP!?44! 7/&'/*.2!,2/(!(,7)*'! .8/! 4&-/4)*'! ;7#.#:#4A! ,*4/22! #.8/7D)2/! 2.&./(A! D/7/! .8#2/! ;7#O)(/(! -<!F/*)2;8/7/P!!Y*).)&44<A! Iµ'! #6! .#.&4! >U?!D&2! ;#4<&(/*<4&./(! .87#,'8! &! IB!$)*,./! )*:,-&.)#*! &.![a°:!#6!&!6)*&4!7/&:.)#*!$)T!:#*.&)*)*'!IT!7/&:.)#*!-,66/7A!LPB$=!=*34LA!IuaBc!2.#:K!?"%! $)T! &*(! IuIB! ;#4<?! ;#4<$/7&2/! /*R<$/! &*(! Iµ'! #6! .#.&4! >U?P! ! "8/!;#4<&(/*<4&./(!>U?!D&2!-)#.)*!4&-/4/(!.87#,'8!.8/!&(().)#*!#6!C4&28"&'!X)#.)*!G+>!5)'&.)#*!=)T! &*(!"_!9U?! 4)'&2/A! 6#44#D/(! -<! &! [c!$)*,./! )*:,-&.)#*! &.! LB°:P! "8/!7/&:.)#*!D&2!2.#;;/(!-<!&(().)#*!#6!LPBµ4!G+>!2.#;!2#4,.)#*P!?!Lµ4! &4)S,#.!#6!/&:8!2&$;4/!D&2! 7/$#O/(! &*(! ,2/(! )*! &*! H*R<$/! 5)*K/(!W4)'#2#7-/*.! ?22&<! MH5W+?N!&22&<!.#!:#*6)7$!2,::/226,4!-)#.)*!4&-/4)*'!#6!/&:8!2&$;4/P!!
B@A@=@B!R#[6-%!Q(#9%:!\.()+&+18%#'!7&&*6!XRQ\K7Y!*&&*6!"#! :#*6)7$! 2,::/226,4! 4&-/4)*'! #6! /&:8! 2&$;4/! ,2/(! )*! .8/!$):7#&77&<! &*&4<2)2A! &*!H5W+?!S,&4).<! :#*.7#4!&22&<!D&2!;/76#7$/(!&2!;/7! .8/!$&*,6&:.,7/72! )*2.7,:.)#*2!MF/*)2;8/7/NP!!X7)/64<A!IT!2;#..)*'!#4)'#*,:4/.#.)(/2!D/7/!&((/(!)*.#!.8/!&;;7#;7)&./!
! BL!
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Table v – Antibodies used in ChIP experiments. !
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Gene UPL Flanking oligos (5'-3') 
!-Actin 77 ccgaaagttgccttttatgg 
    caaaggcgaggctctgtg 
GAPDH 44 cccgtccttgactccctagt 
    gtgatcggtgctggttcc 
sm-22% 44 agcgtcctggatctctctca 
    tctgcactagccaagtcatcc 
ARX 63 ccagccatgagcaatcagt 
    tggagatttacttttgcactcg 
NKX2.3 52 tgaggggacgcaattttct 
    aatttctcgccctcgtcttc 
!
Table vi - Details of the flanking primers and UPL probes used in ChIP-qPCR 
experiments. !
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Figure 3.1.1 – The biogenesis and function of miRNAs – Primary miRNA transcripts 
are processed to pre-miRNA stem-loops of ~60nt in length by Drosha.  The pre-
miRNA is exported from the nucleus by Exportin before being further processed to a 
~21nt mature RNA duplex.  The functional strand of the miRNA duplex is loaded into 
the RNA-induced silencing complex (RISC) and mediates the repression of target 
mRNAs by mRNA degradation or translation inhibition.  Figure adapted from Lodish et 
al. 2008. 
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Figure 3.1.2 – Types of miRNA target sites - A-C - Indicate 7-8nt seed matches with 
vertical dashes representing Watson-Crick base pairing.  D-E - Marginal sites with 6nt 
base pairing within the seed region.  F-G – Sites in which 3’ pairing is able to either 
increase the efficacy of a seed match or compensate for weak base pairing within the 
see region.  Figure adapted from (Bartel et al. 2009). !
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Figure 3.2.1 - All RNA samples used in Affymetrix GeneChip"  miRNA 
expression arrays were efficiently labeled - Total RNA samples isolated from three 
healthy and three moderate asthmatic ASMC cultures were labeled using the 
Genisphere FlashTag Labeling System.  An aliquot of each sample was treated with 
streptavidin-horseradish peroxidase and vigorously washed before the addition of TMB 
substrate.  The metabolism of TMB by horseradish peroxidase and concomitant colour 
generation was measured by absorbance at a wavelength of 450nm.  The dotted 
horizontal line represents an OD reading of greater than 0.1 above the negative control, 
which corresponds to the manufacturers recommendation for successful labeling. !
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Figure 3.2.2 - Hybridization and scanning of Affymetrix miRNA arrays is 
consistent across samples - Quality control of Affymetrix miRNA arrays performed 
in the Affymetrix miRNA QC Tool demonstrates the mean intensities for probe 
replicates complementary to Genisphere spike-in controls added during the labeling 
protocols (A) and Affymetrix Bio-hybridization controls added during the 
hybridization (B and C).  The Y-axis demonstrates the normalised probe intensities 
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  Healthy 1 Healthy 2 Healthy 3 Asthmatic 1 Asthmatic 2 Asthmatic 3 
Healthy 1 1.00 0.99 0.99 0.98 0.98 0.96 
Healthy 2 0.99 1.00 0.99 0.99 0.98 0.96 
Healthy 3 0.99 0.99 1.00 0.99 0.98 0.99 
Asthmatic 1 0.98 0.99 0.99 1.00 0.98 0.98 
Asthmatic 2 0.98 0.98 0.98 0.98 1.00 0.96 
Asthmatic 3 0.96 0.96 0.99 0.98 0.96 1.00 !
Table vii – Pearson’s correlation coefficient values for inter-array comparisons 
performed in the Affymetrix miRNA QC Tool – The table shows the Pearson’s correlation 
coefficient values generated following the comparison of indicated pairs of ASMC cultures in 
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Figure 3.2.8 - Unsupervised hierarchical clustering is unable to differentiate 
cultured ASMCs isolated from healthy or moderate asthmatic individuals based 
upon their miRNA expression profile - Raw .cel files generated by the Affymetrix 
GCOS software were imported into Partek Genomics Suite and analysed by the 
default miRNA expression analysis workflow.  Intensity levels for all human miRNA 
probe sets were clustered in an unsupervised manner using Euclidean Dissimilarity 
and Average Linkage.  
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Figure 3.2.9 - Hierarchical clustering of miRNAs with a difference in expression 
of greater than 1.5-fold between cultured ASMCs isolated from moderate 
asthmatic patients compared to those from healthy individuals – Expression 
levels of miRNAs were compared in moderate asthmatic and healthy replicates by 
ANOVA before Euclidean Dissimilarity and Average Linkage were used to cluster 
those miRNAs that demonstrated a difference in expression of greater than 1.5-fold.  
A total of 218 probesets directed against human miRNAs showed a fold difference in 
expression of greater than 1.5-fold, with 107 and 111 probesets demonstrating higher 
expression in the asthmatic and healthy samples respectively.  The heatmap is 
coloured by relative difference in expression, with red indicating increased expression 
and blue decreased expression.  The strength of the colour represents the magnitude 
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Figure 3.2.10 - Hierarchical clustering of the 37 miRNAs that demonstrated 
differential expression between cultured ASMCs isolated from healthy or 
moderate asthmatic individuals that was greater than 1.5-fold and significant at 
p<0.05 as determined by ANOVA – Expression levels of miRNAs were compared 
between moderate asthmatic and healthy samples by ANOVA. Euclidean 
Dissimilarity and Average Linkage were used to cluster those small RNAs that 
demonstrated a difference in expression that was greater than 1.5-fold and significant 
at p<0.05.  A total of 37 probesets directed against human miRNAs passed these 
thresholds, with 18 and 19 probesets demonstrating higher expression in the asthmatic 
and healthy samples respectively. The heatmap is coloured by relative difference in 
expression, with red indicating increased expression and blue decreased expression.  
The strength of the colour represents the magnitude of the relative difference in 




-(IJ7! 4>$*.0%! T+.:><,*#)%! O(1%/'(+#!+2!/,*#)%!82&V$)>VIaV2.&7z2.! cPccc`cccbL! [PLBc_[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VIBBz2.! cPcLL`I[! [PIJB`B! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VBb_z2.! cPc_bB_LI! LPJLbBa! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V``_z2.! cPcLbcLc[! LP`bb`L! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VI[bz2.! cPcIb`[bL! LP_BJ[B! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VILBaz2.! cPc_bcB[B! LPI__`! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VIL`_z2.! cPcLL`I[! IPJbL_[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJ[z2.! cPccaJBBa_! IPJ`b[`! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VLIbVLV2.&7z2.! cPcIJI__! IPbbL[J! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VILB-VIV2.&7z2.! cPc[La`Ja! IPb_bLb! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJJ-V2.&7z2.! cPcL[[cLJ! IPaBBB`! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V_bbV2.&7z2.! cPcIJ_[_`! IPa[cJ! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VBcBV2.&7z2.! cPc[_bLJ_! IP`b[cI! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VBL`&z2.! cPcLBaIIb! IPBJ`b[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VBIJ/V2.&7z2.! cPcc[aI_BI! IPB`_`_! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJ[V2.&7z2.! cPc_Lb[aB! IPB`LJ[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJLLz2.! cPc_[BI[J! IPB_`[I! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V_b_z2.! cPc_`[[_B! IPBc_cB! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V_L[VB;z2.! cPcc_I[cbI! IPBcLB[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VLI_V2.&7z2.! cPc_Jb_a`! VIPB_c`B! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VJ[Jz2.! cPc_`ba_J! VIP`bI`L! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V[[cV[;z2.! cPc_IaJba! VIPaLLBJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VILb_z2.! cPccJa`I[! VIPa`LBI! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V`Bcz2.! cPc[bIL_L! VIPbJB_L! G/&4.8<!(#D*!O2!=#(/7&./!82&V4/.Va(V2.&7z2.! cPc___caI! VLPca[BJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VI[B&V2.&7z2.! cPc[baaI_! VLPcb_! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VILc_z2.! cPcIa`a[b! VLPcJL`I! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VIbI:V2.&7z2.! cPc[BIJ_I! VLPI_aJJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V[`LV[;z2.! cPccIaIcBI! VLPIabI`! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>Va`JVB;z2.! cPcLBIbII! VLPLca`L! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VB_b(V[;z2.! cPcI`J[cb! VLPLBb`J! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VIB&V2.&7z2.! cPc[L`aI`! VLPLJB`a! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V`LLz2.! cPcL`B`J[! V[Pc_I[J! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VbbJz2.! cPc_Ja__J! V[P[`[BI! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VILbz2.! cPc[[baLB! V[P`La[[! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V[_-z2.! cPc_`[I`[! V[Paab_[! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VBBaz2.! cPcIB`B`I! V[PJ`LLI! G/&4.8<!(#D*!O2!=#(/7&./!
Table viii – ANOVA identified 37 miRNAs with a difference in expression level of 
greater than 1.5-fold and statistical significance of p<0.05 between the healthy and 
moderate asthmatic ASMC cultures analysed – ANOVA was performed in Partek 
Genomics Suite 2.0 to compare the expression level of miRNAs in cultured ASMCs isolated 
from either healthy or moderate asthmatic individuals.  37 miRNAs were found have a 
difference in average expression of greater than 1.5-fold that was statistically significant at a 
value of p<0.05, with 18 and 19 probesets demonstrating higher expression in the asthmatic 
and healthy samples respectively. 
 
! JJ!









































































































































































































































































































































































(#:($(:0*.&!9,/! .#! .8/! 6&:.! .8&.! .8/!$)>U?!$):7#&77&<!/T;/7)$/*.2!D/7/!,2/(!&2!;7/4)$)*&7<!2:7//*2A! D).8! #*4<! .87//! -)#4#'):&4! 7/;4):&./2! &*&4<2/(! 6#7! -#.8! 8/&4.8<! &*(!$#(/7&./!&2.8$&.):!'7#,;2A!&!2,-2/.!#6!.8#2/!$)>U?2!.8&.!(/$#*2.7&./(!&!;#./*.)&4!()66/7/*:/!)*!/T;7/22)#*!-/.D//*!.8/!8/&4.8<!&*(!$#(/7&./!&2.8$&.):!2&$;4/2!D/7/!)*O/2.)'&./(! 6,7.8/7! .87#,'8!>"VS%3>!2.,()/2P! !"8)2!&*&4<2)2!D&2!;/76#7$/(!,2)*'!
H1+8%&%'!"O! 4>$*.0%! T+.:><,*#)%! O(1%/'(+#!+2!/,*#)%!82&V$)>VIBBz2.! cPcLL`I[! [PIJB`B! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VI[bz2.! cPcIb`[bL! LP_BJ[B! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJ[z2.! cPccaJBBa_! IPJ`b[`! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VILB-VIz2.! cPc[La`Ja! IPb_bLb! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJJ-V2.&7z2.! cPcL[[cLJ! IPaBBB`! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VBcBV2.&7z2.! cPc[_bLJ_! IP`b[cI! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VJ[V2.&7z2.! cPc_Lb[aB! IPB`LJ[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V_b_z2.! cPc_`[[_B! IPBc_cB! G/&4.8<!,;!O2!=#(/7&./!82&V$)>V_L[VB;z2.! cPcc_I[cbI! IPBcLB[! G/&4.8<!,;!O2!=#(/7&./!82&V$)>VLI_V2.&7z2.! cPc_Jb_a`! VIPB_c`B! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VJ[Jz2.! cPc_`ba_J! VIP`bI`L! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>V[[cV[;z2.! cPc_IaJba! VIPaLLBJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V4/.Va(V2.&7z2.! cPc___caI! VLPca[BJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VI[B&V2.&7z2.! cPc[baaI_! VLPcb_! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VIbI:V2.&7z2.! cPc[BIJ_I! VLPI_aJJ! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>Va`JVB;z2.! cPcLBIbII! VLPLca`L! G/&4.8<!(#D*!O2!=#(/7&./!82&V$)>VILbz2.! cPc[[baLB! V[P`La[[! G/&4.8<!(#D*!O2!=#(/7&./!
Table ix – miRNAs called as detectable by the Affymetrix miRNA QC Tool and 
identified as being differentially expressed between healthy and moderate 
asthmatic ASMCs – miRNAs defined as being detected above background and 
identified as differentially expressed by an ANOVA comparing expression in healthy 
and asthmatic ASMCs using using thresholds of a difference in expression of greater 
than 1.5-fold and p<0.05. 
 
! IcL!
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Figure 3.2.12 – Normalised intensity values of miRNAs chosen for RT-qPCR follow-
up studies – The normalised intensity values as generated by Partek Genomics Suite for a 
chosen miRNA in each biological replicate.  The x-axis demonstrates the normalised 
intensity signal (log2 transformed) and error bars represent SEM.  Statistical significance 
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Table x – Details of volunteers from whom bronchial biopsies were taken to 
generate the ASMC cultures used in the RT-qPCR miRNA expression profiling  !
! IcB!
Figure 3.2.13 - RT-qPCR analysis of a subset of miRNAs that demonstrated 
potential differential expression between cultured ASMCs isolated from healthy 
individuals compared to those isolated from moderate asthmatic individuals – 
Cultured ASMCs isolated from either healthy or moderate asthmatic individuals were 
growth arrested by a 72 hour incubation in serum-free media.  RNA was harvested from 
5x105 cells and DNase treated before miRNA-specific stem loop RT-qPCR was 
performed.  Relative levels of each indicated miRNA were determined by ''Ct 
methodology using RNU6B as the endogenous control and expression levels are 
presented relative to the individual sample with the highest level of expression.  *** 
p<0.0005 and * p<0.05 as determined by a Mann-Whitney U Test, the horizontal line 
represents the median sample for each miRNA and the whiskers represent the inter-
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Figure 4.2.1 - Mature miR-155 and its housing transcript BIC are expressed at 
lower levels in cultured ASMCs isolated from moderate asthmatic compared to 
healthy individuals! – Cultured ASMCs isolated from either healthy or moderate 
asthmatic individuals were growth arrested by a 72 hour incubation in serum-free 
media.  RNA was harvested from 5x105 cells and DNase treated before RT-qPCR was 
performed for mature miR-155 or the full BIC transcript.  Relative levels of the mature 
miR-155 transcript were determined by ''Ct methodology using A) RNU6B or B) let-
7b as the endogenous control.  Expression levels are shown relative to the sample with 
the highest miR-155 expression.  C) Relative BIC levels as determined through ''Ct 
methodology using 18S as the endogenous control gene.  Expression levels are shown 
relative to the sample with the highest level of BIC expression.  The horizontal bar 
represents the sample with the median relative expression level and the whiskers 
represent the interquartile range, n=7 or 8, *** p<0.0005, ** p<0.005, *p<0.05 as 
determined by a Mann-Whitney U test. !
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Gene TargetScan miRANDA PITA Literature 
BACH1 YES YES YES YES (Skalsky 2007) 
H6PD NO NO NO NO 
          
ETS YES YES YES YES (Romania 2008) 
FOS YES NO YES YES (Gottwein 2007) 
JARID2 YES YES YES YES (Bolisetty 2009) 
MYLK YES YES YES NO 
RhoA NO NO NO YES (Kong 2008) 
Septin 11 YES YES YES NO 
!
Table xi – The occurrence of candidate miR-155 target genes in bioinformatics 
predictions – Shows the occurrence of candidate miR-155 target genes chosen for 
further investigation in target prediction algorithms and any prior reports of miR-155 
specific regulation reported in the literature.  In addition the occurrence of BACH1 
and H6PD, used as a positive and negative control respectively, is also shown. !
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Figure 4.2.2 - CaCl2 mediated transfection of pre-miR-155 facilitates the over-
expression of miR-155 in HEK293 cells – HEK293 cells were transfected with either 
non-targeting pre-miR-Control or pre-miR-155 using CaCl2 methodology and 
incubated for 24 hours before RNA was harvested.  RT-qPCR was performed and 
results are shown following correction for RNU6B as the endogenous control.  
Expression levels are expressed relative to cells transfected with 10nM pre-miR-155.  
Error bars represent SEM, n=3. !
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Figure 4.2.3 – The over-expression of miR-155 in HEK293 cells allows the 
determination of miR-155 mediated regulation of a co-transfected pGL4.13 
luciferase expression plasmid – pGL4.13 luciferase expression plasmids with a 
fragment from the 3’UTR of either A) BACH1, which contains three predicted miR-
155 target sites or B) H6PD, which contains no predicted miR-155 target sites, cloned 
directly 3’ of the luciferase coding sequence were transfected into HEK293 cells.  In 
addition co-transfection with no small RNA, non-targeting pre-miR-Control or pre-
miR-155 was performed.  Following a 24 hour incubation the cells were lysed and 
luciferase activity assessed using the Promega Dual Luciferase Reporter Assay.  
Results are expressed relative to the luciferase activity of cells with no small RNA 
transfected after subtraction of background luciferase activity and correction for 
Renilla luciferase activity as a transfection control.  Error bars represent SEM, n=3. 
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Figure 4.2.4 - The majority of predicted miR-155 target sites facilitate miR-155 
mediated regulation during in vitro luciferase assays – Predicted miR-155 target 
sites within the 3’UTRs of candidate target genes were cloned directly downstream of 
the pGL4.13 Firefly luciferase coding sequence.  Each individual plasmid was co-
transfected into HEK293 cells in parallel with pRL-TK as a transfection control and 
either no small RNA, non-targeting control pre-miR or pre-miR-155 using CaCl2 
methodology.  Following a 24 hour incubation the cells were lysed and luciferase 
activity assessed by the Promega Dual Luciferase Reporter Assay.  Results are 
expressed relative to the luciferase activity of cells with no small RNA transfected after 
substraction of background luciferase activity and correction for Renilla luciferase as a 
transfection control. The small RNA transfected is indicated on the X-axis of the 
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Figure 4.2.5 - Lipofectamine mediated transfection of small RNAs into cultured 
ASMCs – ASMCs were growth arrested by serum starvation for 72 hours before 
Lipofectamine 2000 mediated transfection of FAM-labeled non-targeting pre-miR or 
anti-miR control was performed to ascertain transfection efficiency.  Following a 24 
hour incubation the cells were harvested by Trypsin-EDTA and assessed for successful 
transfection by flow cytometry.  A) Mock transfected sample showing the gating 
strategy for live cells, B) mock transfected cells, C) cells transfected with 20nM FAM-
labeled pre-miRNA control and D) cells transfected with 100nM FAM-labeled anti-
miR control.  Plots are representative from one of six experiments. 
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Figure 4.2.6 – Assessment of the optimal concentration of pre-miR and anti-miR 
for ASMC transfections – ASMCs were growth arrested by serum starvation for 72 
hours before Lipofectamine 2000 mediated transfection of A) FAM-labeled non-
targeting pre-miR or B) FAM-labeled non-targeting anti-miR.  Following a 24 or 72 
hour incubation cells were harvested with Trypsin-EDTA and assessed for successful 
transfection as determined by a positive FAM signal in flow cytomtery (n=1). 
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Figure 4.2.7 - Lipofectamine mediated transfection of pre-miR-155 into cultured 
ASMCs results in an increase the level of detected mature miR-155 - ASMCs were 
growth arrested by serum starvation for 72 hours before Lipofectamine 2000 mediated 
transfection of 4nM or 20nM non-targeting pre-miR control or pre-miR-155.  Mock 
transfections with Lipofectamine only were also performed as controls. Following an A) 
6 hour, B) 24 hour or C) 72 hour incubation RNA was harvested and RT-qPCR 
performed.  Results are analysed using ''Ct methodology through normalisation to 
RNU6B RNA as the endogenous control and expression levels are presented relative to 
the mock transfected sample for each specific time point post-transfection.  Graphs are 
representative of 4 or 5 separate transfections. 
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Figure 4.2.8 - Lipofectamine mediated transfection of anti-miR-155 into cultured 
ASMCs results in a decrease in the level of detected mature miR-155 - ASMCs were 
growth arrested by serum starvation for 72 hours before Lipofectamine 2000 mediated 
transfection of either 100nM non-targeting anti-miR control or 100nM anti-miR-155. Mock 
transfections with Lipofectamine only were also performed as controls.  Following a 24 
hour incubation RNA was harvested and RT-qPCR performed.  Results are analysed using 
''Ct methodology through normalisation to RNU6B RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample.  Data are 
representative of 4 separate transfections. 
 
Figure 4.2.9 - Transfection of small RNAs does not influence the viability of cultured 
ASMCs – ASMCs were growth arrested by serum starvation for 72 hours before 
Lipofectamine 2000 mediated transfections.  The cells were incubated for either 6, 24 or 
72 hours post-transfection before being harvested with Trypsin-EDTA and assessed for 
viability using Invitrogen Live/Dead Staining Kit.  Error bars represent SEM, n=5 for 24 
hours and 4 for 6 and 72 hours. 
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Figure 4.2.10 – Analysis of RhoA mRNA levels following miR-155 over-
expression in cultured ASMCs - ASMCs were growth arrested by serum starvation 
for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-targeting 
pre-miR control or 20nM pre-miR-155.  Following a 6, 24 or 72 hour incubation 
RNA was harvested and RT-qPCR performed.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample for each time 
point post-transfection.  Error bars represent SEM, n=4 for 6 and 72 hours and n=5 
for 24 hours.  Results were tested for statistical significance using Friedmann’s Test 
with Dunn’s Multiple Comparison Correction Test. 
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Figure 4.2.11 - Antagonism of miR-155 function in cultured ASMCs does not 
result in an increase in the abundance of RhoA mRNA - ASMCs were growth 
arrested by serum starvation for 72 hours before Lipofectamine 2000 mediated 
transfection of 100nM non-targeting anti-miR control or 100nM anti-miR-155.  
Following a 24 hour incubation RNA was harvested and RT-qPCR performed.  
Results are analysed using ''Ct methodology through normalisation to 18S RNA as 
the endogenous control and expression levels are presented relative to the mock 
transfected sample.  Error bars represent SEM, n=4. 
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Figure 4.2.12 - Over-expression of miR-155 in cultured ASMCs does not cause a 
decrease in RhoA protein levels - ASMCs were growth arrested by serum starvation 
for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-targeting 
pre-miR control or 20nM pre-miR-155.  Following a 6, 24 or 72 hour incubation 
protein was harvested using a NE-PER kit.  35µg of cytoplasmic protein extract per 
well was electrophorised through a polyacrylamide gel before transfer to a 
nitrocellulose membrane and determination of the level of RhoA and GAPDH by 
western blot. A) Shows a representative blot of RhoA and GAPDH protein for 1 
experiment.  B) Shows the mean relative expression of RhoA protein for 3 independent 
experiments when protein was harvested 24 hours post-transfection. Band intensities 
were calculated using ImageQuant software, before correction of RhoA levels for 
GAPDH as a loading control.  Relative levels are expressed in relation to mock 
transfected samples.  Error bars represent SEM, n=3. 
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Figure 4.2.13 - Antagonism of miR-155 function does not result in an increase in 
the level of RhoA protein -  ASMCs were growth arrested by serum starvation for 72 
hours before Lipofectamine 2000 mediated transfection of 100nM non-targeting anti-
miR control or 100nM anti-miR-155.  Following a 24 hour incubation protein was 
harvested using a NE-PER kit. 35µg of cytoplasmic protein extract per well was 
electrophorised through a polyacrylamide gel before transfer to a nitrocellulose 
membrane and determination of the level of RhoA and GAPDH by western blot. A) 
Shows a representative blot of RhoA and GAPDH protein.  B) Shows the densitometric 
analysis of bands performed using ImageQuant software.  The intensity of the RhoA 
bands was corrected for GAPDH as a loading control and expression levels are 
expressed relative to a mock transfected sample.  n=1. 
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Figure 4.2.14 – Analysis of MYLK mRNA levels following miR-155 over-
expression in cultured ASMCs - ASMCs were growth arrested by serum starvation 
for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-targeting 
pre-miR control or 20nM pre-miR-155.  Following a 6, 24 or 72 hour incubation RNA 
was harvested and RT-qPCR performed.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample for each time 
point post-transfection.  Error bars represent SEM, n=4 for 6 and 72 hours and n=5 for 
24 hours. * p<0.05 as determined by Friedman’s Test with Dunn’s Multiple 
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Figure 4.2.15 - Antagonism of miR-155 function in cultured ASMCs does not 
result in an increase in the level of MYLK mRNA - ASMCs were growth arrested 
by serum starvation for 72 hours before Lipofectamine 2000 mediated transfection of 
100nM non-targeting anti-miR control or 100nM anti-miR-155.  Following a 24 hour 
incubation RNA was harvested using TRIzol methodology and RT-qPCR was 
performed.  Results are analysed using ''Ct methodology through normalisation to 
18S RNA as the endogenous control and expression levels are presented relative to the 
mock transfected sample for each specific time point post-transfection.  Error bars 
represent SEM, n=4.  Results were tested for statistical significance using Friedman’s 
Test with Dunn’s Multiple Comparison Correction Test. n=4.  
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Figure 4.2.16 – Manipulation of the level of miR-155 in cultured ASMCs does not 
result in a clear alteration in the levels of MYLK protein - ASMCs were growth 
arrested by serum starvation for 72 hours before Lipofectamine 2000 mediated 
transfections were performed.  A) Cells were mock transfected or transfected with 20nM 
non-targeting pre-miR control or pre-miR-155 and following a 6, 24 or 72 hour incubation 
protein was harvested using a NE-PER kit.  35µg of cytoplasmic protein extract per well 
was electrophorised through a polyacrylamide gel before transfer to a nitrocellulose 
membrane and probed with an anti-MYLK antibody.  B) Cells were transfected as either 
mock or with 100nM non-targeting anti-miR control or anti-miR-155 before western 
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Figure 4.2.17 - Validation of efficient Affymetrix U133.2 microarray hybridization – 
Affymetrix Eukaryotic Hybridization Controls were spiked into the sample labelling and 
hybridization steps at known concentrations to ensure that labelling, hybridization and 
scanning occurred efficiently and consistently across all arrays.  The Y-axis represents the 





Figure 4.2.18 - The ratio of normalised intensities for probes directed against the 3’ or 
5’ end of control transcripts indicates that the RNA samples have not degraded during 
labeling and hybridization procedures – Normalised intensity values for probes directed 
to either the 3’ or 5’ end of various control probes were assessed to determine if they 
produced an equal signal intensity.  Ratios of 3’ to 5’ signal of greater than three (indicated 
by the horizontal line) represent RNA with levels of degradation above that deemed 
acceptable by the Affymetrix guidelines. 
 
! IBc!
Figure 4.2.19 - The total array content intensity profile is similar for all samples 
analysed on the Affymetrix U133.2 microarrays – Quality control analysis performed in 
Partek Genomics Suite indicates the range of normalised intensities for all probe sets on the 
Affymetrix U133.2 microarrays. 
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Figure 4.2.21 - Unsupervised hierarchical clustering of total mRNA expression 
demonstrates that cells transfected with pre-miR-155 have the least similarity in 
comparison to the alternative transfections – Unsupervised hierarchical clustering 
using Euclidean Dissimilarity and Average Linkage was performed to determine the 
relative similarity in overall mRNA expression levels between mock, 20nM pre-miR-
155, 20nM non-targeting pre-miR control, 100nM anti-miR-155 and 100nM non-
targeting anti-miR control transfected samples.  Branch points represent clustering of 
more similar samples. 
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Figure 4.2.22 – Hierarchical clustering of the 127 probe sets that demonstrated a 
greater than two-fold difference in normalised intensity following transfection of 
20nM pre-miR-155 compared to 20nM non-targeting pre-miR control – 
Expression levels of mRNAs were compared in cultured ASMCs transfected with 
either 20nM pre-miR-155 or 20nM non-targeting control pre-miR before Euclidean 
Dissimilarity and Average Linkage were used to cluster those mRNAs that 
demonstrated a difference in expression of greater than two-fold.  The relative 
intensities of each probe set following mock, 100nM non-targeting control anti-miR 
and 100nM anti-miR-155 transfections are also included for comparison.  All total of 
127 probe sets showed a fold difference of greater than two-fold difference in 
normalised intensity, with 37 probe sets demonstrating a decrease in intensity 
following transfected with pre-miR-155 and 91 probe sets demonstrating an increase 
in intensity.  The heatmap is coloured by relative difference in expression, with red 
indicating increased expression and blue indicating decreased expression.  The 
strength of the colour represents the magnitude of the relative difference in 
expression with a stronger colour indicating a larger difference. 
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Figure 4.2.23 – Hierarchical clustering of the 37 probe sets that demonstrated a 
greater than two-fold decrease in normalised intensity following transfection with 
20nM pre-miR-155 in comparison to 20nM non-targeting pre-miR control - 
Expression levels of mRNAs were compared in cultured ASMCs transfected with 
either 20nM pre-miR-155 or 20nM non-targeting control pre-miR before Euclidean 
Dissimilarity and Average Linkage were used to cluster those mRNAs that 
demonstrated a normalised intensity value that was at least two-fold lower following 
transfection with 20nM pre-miR-155. The relative intensities of each probe set 
following mock, 100nM non-targeting control anti-miR and 100nM anti-miR-155 
transfections are also included for comparison.  The heatmap is coloured by relative 
difference in expression, with red indicating increased expression and blue indicating 
decreased expression.  The strength of the colour represents the magnitude of the 





Fold Change v Non-
targeting Control 
Fold Change v 
Mock 
FIP1L1 3.01756 1.94054 
KBTBD10 2.74785 2.5881 
PCTK2 2.44799 1.4953 
BC025664 2.2931 1.77312 
MALAT1 2.28623 1.50398 
CCND2 2.27764 1.53397 
RAPGEF6 2.2674 1.79573 
COL21A1 2.25223 1.97494 
IGSF10 2.23272 2.08094 
SLITRK6 2.2308 1.81272 
PUS10 2.20533 1.37177 
ZNF652 2.20204 1.78773 
SNAP25 2.19306 1.91865 
chr15:94554756-
94556856 2.14844 1.79486 
KIAA1211 2.1468 1.79544 
KCND2 2.13827 2.04751 
PAN3 2.13657 1.90256 
BRWD1 2.11875 1.46855 
G3BP1 2.1161 1.98357 
ITGA8 2.10929 2.14221 
NDUFS1 2.10658 1.97514 
FILIP1 2.0985 1.63428 
ZNF323 2.06606 1.44975 
ABAT 2.04711 1.49667 
ADAMTS5 2.04488 2.08358 
SOX5 2.04167 1.51462 
FAM164A 2.04113 1.91148 
GAB2 2.03726 1.70246 
CD24 2.0352 2.52899 
ADAMTS5 2.03315 2.12286 
MBNL1 2.02498 1.62783 
ADAMTS5 2.02335 2.05641 
EVI2A 2.02257 1.12439 
C15orf5 2.01262 1.43461 
NKTR 2.01128 1.33426 
SEMA3A 2.00256 1.35622 
KIAA2026 2.00048 1.8956 !
Table xii – Genes with a greater than 2-fold decrease in expression following 
transfection with 20nM pre-miR-155 - Indicates genes with a greater than 2-fold 
decrease in expression in the pre-miR-155 transfected sample compared to the non-
targeting pre-miR control sample.  The fold difference relative to Mock transfected 
cells is included for comparison. 
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Figure 4.2.24 – Hierarchical clustering of the 91 probe sets that demonstrated a 
greater than two-fold increase in normalised intensity following transfection with 
20nM pre-miR-155 in comparison to 20nM non-targeting pre-miR control – 
Expression levels of mRNAs were compared in cultured ASMCs transfected with either 
20nM pre-miR-155 or 20nM non-targeting control pre-miR before Euclidean 
Dissimilarity and Average Linkage were used to cluster those mRNAs that 
demonstrated a normalised intensity value that was at least two-fold greater following 
transfection with 20nM pre-miR-155.  The relative intensities of each probe set 
following mock, 100nM non-targeting control anti-miR and 100nM anti-miR-155 
transfections are also included for comparison.  The heatmap is coloured by relative 
difference in expression, with red indicating increased expression and blue indicating 
decreased expression.  The strength of the colour represents the magnitude of the 
relative difference in expression with a stronger colour indicating a larger difference. 
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Gene Fold Change v Non-targeting 
Control 
Fold Change v Mock 
KIF5C 5.98847 6.57523 
IDO1 4.69136 5.11367 
PMAIP1 4.44712 5.95504 
CCL5 4.39149 5.02007 
CXCL10 3.798 5.2261 
GCH1 3.77368 4.52995 
PMAIP1 3.62381 5.62405 
DNER 3.33893 4.71107 
TM7SF2 3.0544 3.0737 
CCL8 3.03614 4.93214 
ISG20 3.02472 3.38274 
ZC3HAV1 2.9738 2.15602 
IRF1 2.94669 2.92484 
ISG20 2.91257 3.35001 
GBP5 2.88829 2.69599 
STX11 2.88225 2.90879 
CXCL11 2.86884 7.18668 
GBP4 2.83858 3.10279 
TYSND1 2.82123 2.6898 
CD38 2.78565 2.95523 
FRMD3 2.77228 3.14394 
C1orf173 2.74036 3.52967 
FAM26F 2.68452 2.82849 
CR1L 2.59184 3.43634 
GOLGA4 2.57934 2.13817 
ASPHD2 2.57861 2.85438 
CCL26 2.55726 2.67385 
TNFSF10 2.54987 2.96579 
TYSND1 2.46371 2.66445 
CXCL9 2.42823 2.65424 
OASL 2.42606 2.87678 
WARS 2.38233 2.91251 
FAM26F 2.38097 2.39099 
ENPEP 2.37872 1.88953 
RHBDF2 2.35904 3.2418 
PHACTR4 2.34419 2.13101 
OASL 2.33566 2.67427 
IRF1 2.33491 2.26655 
TMEM171 2.33111 2.61686 
FRMD3 2.32494 2.24395 
TNFSF10 2.32104 2.83838 
CSAG2 /// CSAG3 2.31819 3.09975 
NOD2 2.31084 2.55666 
SLC2A13 2.2619 2.80964 
CR1 /// CR1L 2.24864 3.42512 
NUDCD1 2.2343 2.148 
PLA1A 2.2277 1.88997 
FOSL1 2.22519 2.14761 
SQRDL 2.21758 2.15536 
LOC100131733 2.2132 2.13767 
NCF2 2.21066 2.16498 
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GBP4 2.20991 3.13819 
GDPD3 2.20973 2.03603 
HRASLS2 2.20691 2.99329 
WARS 2.17659 2.66823 
NCRNA00103 2.1745 2.36287 
ATF3 2.16423 2.45034 
AGFG1 2.15959 1.27086 
TNFSF10 2.14998 2.39969 
IL4I1 2.13242 2.43875 
MT1M 2.12688 2.57641 
PCDH17 2.12462 2.06392 
MSX1 2.10695 2.28529 
FLJ32255 2.10306 2.41889 
ALCAM 2.0968 1.38298 
ATP10A 2.09412 1.56562 
LST1 2.08848 1.92429 
STAMBPL1 2.08115 2.21133 
TNFAIP6 2.07527 2.10876 
C10orf10 2.06986 1.75253 
NFE2L3 2.06571 2.25562 
RHEBL1 2.06404 2.28601 
CCL7 2.06155 2.58944 
HMOX1 2.05632 1.83502 
HPSE 2.05529 2.06608 
TNFAIP6 2.05525 2.16795 
DISC1 2.04732 1.51682 
CH25H 2.0371 2.32173 
C9orf91 2.03159 1.83843 
PDZD2 2.02978 2.55694 
DUSP6 2.02758 2.68634 
C10orf140 2.0226 2.79529 
RXRG 2.01266 1.83288 
LOC100128081 2.01226 1.22032 
HMMR 2.00636 1.71596 
ETV7 2.00585 2.32611 
STAMBPL1 2.00227 1.95885 
EHD4 2.00153 1.95977 
!
D@B@F@D!;1*#&/1(4'&!5(',!*.'%1%:!*80#:*#/%!2+..+5(#)!-(I>=LL!*#'*)+#(&-!?2!()2:,22/(!)*!+/:.)#*![P[P[PLA!.8/!'4#-&4!/66/:.2!#6!.8/!&*.)V$)>VIBB!.7&*26/:.)#*!#6!:,4.,7/(! ?+=32! ()(! *#.! &;;/&7! .#! -/! '7#22A! D).8! .8/! #O/7&44! $>U?! /T;7/22)#*!;7#6)4/! 6#44#D)*'! &*.)V$)>VIBB! .7&*26/:.)#*! -/)*'! $#2.! 2)$)4&7! .#! .8&.! #6! :/442!
Table xiii – Genes with a greater than 2-fold increase in expression following 
transfection with 20nM pre-miR-155 – Indicates genes with a greater than 2-fold 
increase in expression in cells transfected with pre-miR-155 compared to the non-
targeting pre-miR control sample.  The fold difference relative to Mock transfected 
cells is included for comparison. 
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Figure 4.2.25 – Hierarchical clustering of the 109 probe sets that demonstrated 
a greater than 1.5-fold difference in normalised intensity following transfection 
with 100nM anti-miR-155 in comparison to 100nM non-targeting anti-miR 
control – Expression levels of mRNAs were compared in cultured ASMCs 
transfected with either 100nM anti-miR-155 or 100nM non-targeting control anti-
miR before Euclidean Dissimilarity and Average Linkage were used to cluster those 
mRNAs that demonstrated a difference in expression of greater than 1.5-fold.  The 
relative intensities of each probe set following mock, 20nM non-targeting control 
pre-miR and 20nM pre-miR-155 transfections are also included for comparison.  A 
total of 109 probe sets showed a fold difference of greater than two-fold difference 
in normalised intensity, with 37 probe sets demonstrating a decrease in intensity 
following transfected with pre-miR-155 and 91 probe sets demonstrating an increase 
in intensity.  The heatmap is coloured by relative difference in expression, with red 
indicating increased expression and blue indicating decreased expression.  The 
strength of the colour represents the magnitude of the relative difference in 
expression with a stronger colour indicating a larger difference. 
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!Figure 4.2.26 – Hierarchical clustering of the 37 probe sets that demonstrated a greater 
than 1.5-fold increase in normalised intensity following transfection with 100nM anti-
miR-155 in comparison to 100nM non-targeting anti-miR control –Expression levels of 
mRNAs were compared in cultured ASMCs transfected with either 100nM anti-miR-155 or 
100nM non-targeting control anti-miR before Euclidean Dissimilarity and Average Linkage 
were used to cluster those mRNAs that demonstrated an increase in expression of greater 
than 1.5-fold following transfection with 100nM anti-miR-155. The relative intensities of 
each probe set following mock, 20nM non-targeting control pre-miR and 20nM pre-miR-
155 transfections are also included for comparison. The heatmap is coloured by relative 
difference in expression, with red indicating increased expression and blue indicating 
decreased expression.  The strength of the colour represents the magnitude of the relative 
difference in expression with a stronger colour indicating a larger difference. 
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Gene Fold Change v anti-miR Control Fold Change v Mock 
DENND1B 1.90558 1.49683 
IZUMO1 1.88031 1.21482 
CXCL11 1.86271 2.21709 
BVES 1.77466 1.40741 
CXCL11 1.77382 2.34534 
ITIH4 1.71185 1.45323 
SULT1C2 1.69592 1.52337 
ZNF254 1.65587 1.67884 
CCL5 1.65308 1.26519 
MGC35361 1.62348 1.46431 
KCNH5 1.61358 1.36567 
chr7:156765361-
156765870 1.61085 1.05554 
ZNF385D 1.60425 1.09884 
POU3F3 1.60338 1.03145 
ISG20L2 1.60007 1.17335 
CEP97 1.59519 1.40711 
GMDS 1.59396 1.34775 
MTND2 1.59393 1.03068 
HPCAL4 1.57304 1.27089 
CCL5 1.56823 1.30724 
C7orf10 1.55904 1.87713 
chr1:8223148-
82234802 1.54769 1.08452 
GPR84 1.54132 1.20296 
LIMD1 1.53598 1.34756 
CISD2 1.53597 1.01675 
BPTF 1.53333 1.84283 
ANO2 1.53171 1.28818 
MMP1 1.53157 2.21117 
SUSD5 1.52429 1.52429 
FKSG2 1.52 1.12661 
HRASLS2 1.51986 1.43679 
GTF2F2 1.51392 1.13714 
ABCC12 1.51044 1.22839 
chr8:82,351,922-
82,352,353 1.50938 1.02283 
chr2:96,349,913-
96,351,371 1.50262 1.01035 
KIAA0564 1.50249 1.50249 
HAUS6 1.50089 1.89748 
!
!
Table xiv – Genes with a greater than 1.5-fold increase in expression following 
transfection with 100nM anti-miR-155 – Indicates genes with a greater than 1.5-fold 
increase in expression in cells transfected with anti-miR-155 compared to non-targeting 
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Figure 4.2.27 - Validation of mRNAs with increased abundance following miR-
155 over-expression in cultured ASMCs - ASMCs were growth arrested by serum 
starvation for 72 hours before Lipofectamine 2000 mediated transfection of 20nM 
non-targeting pre-miR control or 20nM pre-miR-155.  Following a 24 hour incubation 
RNA was harvested and RT-qPCR performed.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the 20nM pre-miR-155 transfected sample.  
Error bars represent SEM, n=5.  * p<0.05 as determined by Friedman’s Test with 
Dunn’s Multiple Comparison Correction Test. 
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Figure 4.2.28 – Analysis of CCL5 and CCL26 mRNA levels following over-
expression of miR-155 in cultured ASMCs - ASMCs were growth arrested by serum 
starvation for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-
targeting pre-miR control or 20nM pre-miR-155.  Following a 6, 24 or 72 hour 
incubation RNA was harvested and RT-qPCR performed.  A) Shows the relative 
expression levels of CCL26 at the indicated times post-transfection and B) shows the 
same analysis for CCL5.  Results are analysed using ''Ct methodology through 
normalisation to 18S RNA as the endogenous control and expression levels are 
presented relative to the 20nM pre-miR-155 transfected sample.  Error bars represent 
SEM, n=4 for 6 and 72 hours and n=5 for 24 hours.  *p<0.05 as determined by 
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Figure 4.2.29 – Determination of whether the concentration of transfected pre-
miR-155 influences the increase in CCL5 mRNA levels - ASMCs were growth 
arrested by serum starvation for 72 hours before Lipofectamine mediated transfection 
of 4nM or 20nM non-targeting pre-miR control or pre-miR-155.  Following a 24 hour 
incubation RNA was harvested and RT-qPCR performed.  A) Shows the relative 
expression of CCL5 mRNA 24 hours post-transfection presented relative to the 20nM 
pre-miR-155 transfected sample.  B) Shows the relative expression of CCL5 mRNA 
24 hours post-transfection relative to the 4nM pre-miR-155 samples, the 20nM pre-
miR-155 sample is not included on this graph.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA and expression levels are expressed 
relative to the to 20nM pre-miR-155 (A) or 4nM pre-miR-155 (B).  Error bars 
represent SEM, n=3.  Statistical significance was determined using a 2-way Friedmans 




Figure 4.2.30 - CCL5 mRNA levels do not decrease following the antagonism of miR-155 
function in cultured ASMCs - ASMCs were growth arrested by serum starvation for 72 
hours before Lipofectamine 2000 mediated transfection of 100nM non-targeting anti-miR 
control or 100nM anti-miR-155.  Following a 24 hour incubation RNA was harvested and RT-
qPCR performed.  Results are analysed using ''Ct methodology through normalisation to 
18S RNA as the endogenous control and expression levels are expressed relative to the mock 
transfected sample.  Error bars represent SEM, n=3. 
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Figure 4.2.31 – Analysis of CCL5 protein levels 24 hours post-transfection with pre-
miR-155 or anti-miR-155 - ASMCs were growth arrested by serum starvation for 72 
hours before Lipofectamine 2000 mediated transfection of 20nM non-targeting pre-miR 
control, 20nM pre-miR-155, 100nM non-targeting anti-miR control or 100nM anti-miR-
155.  CCL5 protein levels in the culture supernatants was determined by ELISA, n=1. !
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Figure 4.2.32 - Validation of mRNAs with decreased levels following miR-155 
over-expression in cultured ASMCs - ASMCs were growth arrested by serum 
starvation for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-
targeting pre-miR control or 20nM pre-miR-15.  Following a 24 hour incubation RNA 
was harvested and RT-qPCR performed.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample.  Error bars 
represent SEM, n=5.  * p<0.05 as determined by Friedman’s Test with Dunn’s 
Multiple Comparison Correction Test. 
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Figure 4.2.33 – Analysis of ZNF652 mRNAs levels following the over-expression 
of miR-155 in cultured ASMCs - ASMCs were growth arrested by serum starvation 
for 72 hours before Lipofectamine 2000 mediated transfection of 20nM non-targeting 
pre-miR control or 20nM pre-miR-155.  Following a 6, 24 or 72 hour incubation RNA 
was harvested and RT-qPCR performed.  Results are analysed using ''Ct 
methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample.  Error bars 
represent SEM, n=4 for 6 and 72 hours and n=5 for 24 hours.  * p<0.05 as determined 




!9/./7$)*&.)#*! #6! gUC`BL!$>U?! 4/O/42! L_! 8#,72! &6./7! .7&*26/:.)#*!D).8! &*.)V$)>VIBB! (/$#*2.7&./(! *#! 2.&.)2.):&44<! 2)'*)6):&*.! ()66/7/*:/! -/.D//*! Icc*=! &*.)V$)>VIBB! .7&*26/:.)#*! D8/*! :#$;&7/(! .#! /).8/7!$#:K! #7! Icc*=! *#*V.&7'/.)*'! :#*.7#4!&*.)V$)>!.7&*26/:.)#*2!MC)',7/!_PLP[BNP! !"8/7/!D&2A!8#D/O/7A!&!24)'8.!.7/*(!.#D&7(2!&*! )*:7/&2/! )*! .8/! 4/O/4!#6!gUC`BL!$>U?! 6#44#D)*'!$)>VIBB!&*.&'#*)2$A!D8):8! )2!D8&.!D#,4(!-/!/T;/:./(!)6!gUC`BL!D&2!)*!6&:.!&!.7,/!/*(#'/*#,2!.&7'/.!#6!$)>VIBB!)*!:,4.,7/(!?+=32P!!@*6#7.,*&./4<A! (,/! .#! .)$/! :#*2.7&)*.2A! *#! 6,7.8/7! )*O/2.)'&.)#*2! )*.#! ;#22)-4/!/*(#'/*#,2!.&7'/.2!#6!$)>VIBB!)*!:,4.,7/(!?+=32!D/7/!;#22)-4/P!!!
Figure 4.2.34 - Determination of whether the concentration of transfected pre-
miR-155 influences the decrease in ZNF652 mRNA levels - ASMCs were growth 
arrested by serum starvation for 72 hours before Lipofectamine 2000 mediated 
transfection of 4nM or 20nM non-targeting pre-miR control or pre-miR-155.  
Following a 24 hour incubation RNA was harvested and RT-qPCR performed.  
Results are analysed using ''Ct methodology through normalisation to 18S RNA as 
the endogenous control and expression levels are presented relative to the mock 
transfected sample.  Error bars represent SEM, n=3, * p<0.05 as determined by a 2-





Figure 4.2.35 – Analysis of ZNF652 mRNA levels following the antagonism of 
miR-155 function in cultured ASMCs - ASMCs were growth arrested by serum 
starvation for 72 hours before Lipofectamine 2000 mediated transfection of 100nM 
non-targeting anti-miR control or 100nM anti-miR-155.  Following a 24 hour 
incubation RNA was harvested and RT-qPCR performed.  Results are analysed using 
''Ct methodology through normalisation to 18S RNA as the endogenous control and 
expression levels are presented relative to the mock transfected sample.  Error bars 
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Figure 5.1.1 – Ribbon traces of a nucleosome particle - ribbon traces for the 146bp 
DNA (brown and turquoise) associated with the eight core histone proteins (blue:H3, 
green:H4, yellow:H2A and red:H2B).  The two views are down the DNA superhelix 
axis for the left particle and perpendicular to it for the right.  Figure taken from Luger 
et al. 1997.  !
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Figure 5.1.2 – Hierarchical formation of chromatin structures – A number of 
protein:protein interactions facilitate the organization of hierarchical structures 
facilitating compaction of DNA into the nucleus of a eukaryotic cell.  Image taken 
from Alberts et al 2002. !
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Figure 5.1.3 – Structure of a lysine residue and the impact of methylation and 
acetylation modifications 
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Figure 5.1.4 – A diagrammatic depiction of the action of ChIP-seq peak finding 
algorithm SICER – A) The reference genome (Red) is divided into 200bp windows (1, 2 
and 3) and the number of uniquely aligned sequences generated from the Input control and 
specific ChIP samples are counted within each window.  If there is a statistically 
significant greater number of aligned reads in the ChIP sample compared to the Input 
(window 1) then a peak is called.  If there is no difference (window 2) or the difference is 
not significant (window 3) then no peak is called.  B) SICER allows the identification of 
broad regions of enrichment as windows without a called enrichment are tolerated within a 
large peak region based on criteria defined by the user.  Green bars indicate called peak 
regions and red bars indicate individual windows that do not display an enrichment but that 
fall within a larger peak region. 
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Figure 5.2.1 - Successful recovery of appropriately sized chromatin fragments 
from cross-linked cultured ASMCs – Approximately 15x106 cultured ASMCs were 
serum starved for 72 hours before being cross-linked with 1% formaldehyde and 
harvested by Trypsin-EDTA treatment and gentle scraping.  Cells were treated with 
detergent and centrifuged through a high concentration sucrose cushion to isolate 
nuclei, which were then treated with Nuclease T7.  S1 represents material released by 
centrifugation performed immediately after Nuclease T7 treatment, whilst Sonic 
represents material released following sonication and centrifugation.  The material in 
the Pellet is that not released following centrifugation.  Results are representative from 







Figure 5.2.2 – qPCR validation of successful and specific H3K4me3 and 
H3K27me3 ChIPs – ChIPs were performed on chromatin isolated from formaldehyde 
cross-linked cultured ASMCs using either anti-H3K4me3, anti-H3K27me3 or isotype 
control IgG.  DNA recovered from the ChIP was analysed by qPCR using primer sets 
proximal to the transcriptional start sites of !-actin, GAPDH, sm22%, ARX or NKX2.3.  
Results are expressed relative to the Input Ct value generated for each specific primer 
set and are representative from a single culture of ASMCs. 
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Figure 5.2.3 – Preparation of an Illumina ChIP-seq library – ChIP-seq libraries 
were prepared from DNA isolated by specific ChIPs using either anti-H3K4me3, anti-
H3K4me1 or anti-H3K27me3 or from Input control DNA that had not been subjected 
to ChIP.  Libraries were prepared according to the manufacturers instructions and 
aliquots were analysed at various steps using an Agilent Bioanalyser to confirm 
successful preparation of the libraries.  A) Shows the DNA ladder run to enable the 
library to be accurately sized, B-D) show the profile of the H3K4me3 library at 
various stages during the process B) shows a library before PCR amplification, C) 
shows the profile of a library immediately following amplification, with the two 
arrowed peaks indicating PCR primers artefacts and D) shows the profile of the 
library following size-selection to remove the PCR primers. !
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Figure 5.2.4 – Run statistics of Illumina next-generation sequencing of Input, 
H3K4me1 ChIP, H3K4me3 ChIP and H3K27me3 ChIP libraries – Four ChIP-seq 
libraries were sequenced using an Illumina GAIIx.  Sequences were called and aligned 
to the reference human genome using Novoalign v2.07.07.  A) Shows the total 
number of reads generated (white bars), those that were aligned to the reference 
genome (light grey bars) and those that could not be mapped to the reference genome 
(dark grey).  The sum of aligned and unmapped reads is equal to the total number of 
reads generated for each library.  The final alignment indicates the final number of 
reads used for downstream analysis following the removal of duplicate reads which 
are generated as a PCR artifact (black bars).  B) Shows the same analysis but 
presented as the percentage of the total number of sequences generated. !
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Figure 5.2.5 – Indicates the number of SICER called regions of H3K4me3 
enrichment in the genome of cultured ASMCs – SICER was run using a window 
size and gap size of 200 base pairs to compare the final aligned sequences from the 
Input and H3K4me3 libraries and define regions that were enriched in the H3K4me3 
library compared to background.  The raw peaks (black bar) indicate the number of 
regions of enrichment initially called by SICER, these were then filtered based on p-
value (grey bar) and subsequently the number of reads in the H3K4me3 library within 
the region of called enrichment (white bar). 
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Figure 5.2.6 – Classifying the location of SICER called regions of H3K4me3 
enrichment in relation to the closest gene – The 16,935 SICER called regions of 
H3K4me3 enrichment were classified based upon their linear distance from the closest 
annotated gene in the RefSeq database using the GenomicAnnotation Tool in 
ChIPSeeqer 2.0. Peaks were classified as those that were associated with annotated 
TSSs (white segment), those that were located within an annotated gene (black 
segment), those that were greater than 3kb but less than 50kb from an annotated gene 
(dark grey segment) and those that were located greater than 50kb from an annotated 
gene (light grey segment).  The bracketed number represents the number of peaks in a 
classification. !!
Figure 5.2.7 – Enrichment of H3K4me3 at an average TSS – Aligned sequences 
from the H3K4me3 ChIP library were analysed using the CEAS tool.  The graphic is 
obtained from the CEAS output file and shows the average distribution of H3K4me3 
sequences from 3kb downstream to 3kb upstream of the TSS of an average gene.   !
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Figure 5.2.8 – Demonstrates the typical enrichment of H3K4me3 over the TSS of 
annotated genes – A) The average level of detectable transcripts from all genes in 
cultured ASMCs was calculated from intensity values generated from Affymetrix 
U133.2 expression arrays.  The chart shows the mean expression of all genes and the 
relative expression of GAPDH, IFFO1 and NOP2. B) Aligned H3K4me3 reads were 
uploaded to the UCSC genome browser as a .bigwig file and regions called as 
enriched by SICER were uploaded as a .bed file.  Regions of SICER called H3K4me3 
enrichment and annotated CpG islands are depicted. Genome co-ordinates and 
annotated RefSeq transcripts are shown at the top and bottom of the figure 
respectively. !
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Figure 5.2.9 – Genes from which high abundance transcripts are derived are 
more likely to be demarcated with a TSS-associated region of H3K4me3 
enrichment than genes producing low levels of transcripts – Loci that had a TSS-
associated SICER-defined region of H3K4me3 enrichment were determined using the 
GenomicAnnotation Tool in ChIPSeeqer.  These loci were compared to Affymetrix 
microarray expression data to determine the relationship between the abundance of a 
transcript and the presence of H3K4me3 enrichment at the gene TSS. 5 bins of 
Refseq transcripts were defined based upon expression levels, with Bin A containing 
the 1000 transcripts with the highest level of detection and subsequent bins of 1000 
transcripts taken at 3000 data point intervals until Bin E, which contains the 1000 
transcripts with the lowest level of detection.   The percentage of transcripts in each 
bin that had a TSS-associated region of H3K4me3 enrichment was then calculated.  !
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Figure 5.2.10 – The normalised tag count of a TSS-associated H3K4me3 
enrichment positively correlates with the level of detectable transcript derived 
from that gene – Normalised tag counts for TSS-associated H3K4me3 enrichments 
were generated by dividing the number of aligned reads in each region of enrichment 
by the total number of aligned reads in the H3K4me3 ChIP-seq sample.  TSS-
associated regions of enrichment were matched to transcripts expression levels using 
RefSeq IDs.  Bins of 1000 transcripts were defined based upon their relative 
expression levels and the mean normalised tag count and mean expression level for 
each bin was calculated.  A) Demonstrates data for all transcript-producing loci 
analysed., B) Demonstrates data for loci with TSS-associated H3K4me3 enrichments 
only.  The Y-axis indicates normalised tag count and the X-axis indicates the relative 
level of expression of the transcript bin (log2).  Correlation was calculated by 
determination of Spearman’s correlation coefficient. 
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Figure 5.2.11 – Differing profiles of H3K4me3 enrichment across the IL-16 locus 
in culture ASMCs and in vitro differentiated Th2 cells – Aligned reads from ChIP-
seq of H3K4me3 libraries generated from anti-H3K4me3 ChIPs in either in vitro 
differentiated Th2 or cultured ASMCs were uploaded to the UCSC genome browser as 
.bigwig files.  SICER-called regions of H3K4me3 enrichment in cultured ASMCs are 
also shown.  Box I demarcates a region of H3K4me3 enrichment in ASMCs over an 
annotated TSS for IL-16, indicating that this is the TSS utlilised in ASMCs.  Box II 
demarcates a region of H3K4me3 enrichment in Th2 cells at a TSS close to the 3’ end 
of the gene, indicating that this is the TSS utilised in Th2 cells. 
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 Total Number of H3K4me3 peaks 
Overlap with AoSMC 
DNase I sites 
(Number)  
Overlap with 
AoSMC DNase I 
sites (%) 
Overall 16935 14058 83.0 
TSS 12089 11345 93.8 
Within Gene 2288 1039 45.4 
>3kb and 
<50kb 1840 1301 70.7 
>50kb 661 340 51.4 
Table xv – Greater than 80% of SICER-defined regions of H3K4me3 enrichment 
in cultured ASMCs overlap a DNase I hypersensitivity site from aortic smooth 
muscle cells – Regions of H3K4me3 enrichment that overlapped with defined regions 
of DNase I hypersensitivity in aortic smooth muscle were identified using the 
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Figure 5.2.14 – The number of SICER called regions of H3K4me1 enrichment in 
the genome of cultured ASMCs – SICER was run using a window size of 200 base 
pairs and gap size of 800 base pairs to compare the final aligned sequences from the 
Input and H3K4me1 libraries and define regions that were enriched in the H3K4me1 
library compared to background.  The raw peaks (black bar) indicate the number of 
regions of enrichment initially called by SICER, these were then filtered based on p-
value (grey bar) and subsequently the number of reads in the H3K4me1 library within 
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Figure 5.2.15 - Classifying the location of SICER called regions of H3K4me1 
enrichment in relation to the closest gene – The 23,528 SICER called regions of 
H3K4me1 enrichment were classified based upon their linear distance from the closest 
annotated gene in the RefSeq database using the GenomicAnnotation Tool in 
ChIPSeeqer 2.0. Peaks were classified as those associated with annotated TSSs (white 
segment), those that were located within an annotated gene (black segment), those that 
were greater than 3kb but less than 50kb from an annotated gene (dark grey segment) 
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Figure 5.2.16 - CEAS report on the distribution of H3K4me1 over an average 
TSS – Aligned sequences from the H3K4me1 ChIP library analysed using the CEAS 
tool.  The graphic is obtained from the CEAS output file and shows the average 
distribution of H3K4me1 sequences from 3kb downstream to 3kb upstream of an 
average TSS of annotated genes. 
 
Figure 5.2.17 - Demonstrates regions of H3K4me1 enrichment flanking a TSS 
enriched with H3K4me3 at the VEGFA gene – Aligned H3K4me1 and H3K4me3 
sequences are depicted as reads/200 base pair window in the UCSC genome browser.  
Regions called as enriched for either H3K4me1 or H3K4me3 by SICER were uploaded 
as .bed files and are displayed as UCSC tracks along with along with annotated CpG 
islands and regions of DNase I hypersensitivity in aortic smooth muscle cells.  Genome 
co-ordinates and annotated RefSeq transcripts are shown at the top and bottom of the 
figure respectively.   
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DNase I (Number)  
Overlap with 
DNase I (%) 
Overall 23528 16805 71.4 
TSS 5739 4798 83.6 
Within Gene 10537 6995 66.4 
>3kb and 
<50kb 4205 3008 71.6 
>50kb 2909 1908 65.6 
Table xvi – Greater than 70% of defined regions of H3K4me1 enrichment in 
cultured ASMCs overlap a DNase I hypersensitivity site from AoSMCs – Regions 
of H3K4me1 enrichment that overlapped with DNase I hypersensitivity sites in aortic 







Figure 5.2.18 – H3K4me1 demarcates both known and possible novel enhancer 
elements upstream of the VEGFA gene – H3K4me1 and H3K4me3 reads/200 base 
pairs were uploaded to the UCSC genome browser as .bigwig files.  SICER defined 
regions of H3K4me1 and H3K4me3 enrichment in cultured ASMCs were uploaded as 
.bed files.  Annotated CpG islands, regions of DNase I hypersensitivity in AoSMCs 
and RefSeq transcripts are shown for comparison.  Boxes I and II (red, ~46kb and 
~56kb) demarcate regions that have been shown as regions that function as enhancer 
elements involved in regulating VEGFA expression.  Box III (blue, ~70kb) 
demarcates a region containing elements marked with H3K4me1 that overlaps DNase 
I hypersensitivity sites in AoSMCs and may represent novel regulatory regions 
involved in regulating VEGFA expression. 
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Figure 5.2.20 – H3K4me1 enrichments demarcate reported and potential novel 
enhancer regions upstream of the VEGFA gene in cultured ASMCs but not Th2 
cells – Comparison of ChIP-seq interrogation of H3K4me1 and H3K4me3 
enrichments in in vitro differentiated Th2 and cultured ASMCs.  H3K4me1 and 
H3K4me3 SICER defined enrichments in ASMCs, AoSMC and Th2 sites of DNase I 
hypersensitivity and CpG islands are shown for reference and comparison.  Boxes I 
and II (Red) indicate previously reported enhancer regions with the ability to regulate 




Figure 5.2.21 – H3K4me1 enrichments demarcate known enhancer regions in the 5q 
locus in Th2 but not ASMCs – Comparison of ChIP-seq interrogation of H3K4me1 
enrichments in in vitro differentiated Th2 and cultured ASMCs.  Box I (Red) shows a 
region known to be a locus control region involved in the regulation of IL-13 expression 
which is demarcated with H3K4me1 in Th2 but not ASMCs.  Box II (Blue) shows a 
known regulatory region at the 5’ end of the IL-4 gene that is demarcated with H3K4me1 
in both Th2 and ASMCs.  
 
! L_[!
Figure 5.2.22 – Detailed view of the profile of H3K4me1 and H3K4me3 enrichments 
around the IL-13 and IL-4 genes in in vitro differentiated Th2 cells and cultured 
ASMCs – Comparison of ChIP-seq interrogation of H3K4me1 enrichments in in vitro 
differentiated Th2 and cultured ASMCs.  The red box shows a region known to be a locus 
control region involved in the regulation of IL-13 expression, which is demarcated with 









Figure 5.2.23 – CTCF binding motifs were enriched in AoSMC DNase I 
hypersensitive sites located within distal regions of H3K4me1 enrichment – Novel 
motif discovery was performed using MEME analysis to search for over-represented 
sequences present within 5000 AoSMC DNase I hypersensitivity sites that were 
located within distal regions of H3K4me1 enrichment.  A) Shows the major motif 
identified by MEME motif discovery analysis.  B) Shows the canonical binding motif 
for CTCF as defined by the JASPAR database. 
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Figure 5.2.24 – Reproducibility of profiles of H3K4me1 and H3K4me3 
enrichment across biological replicates – The number of reads / 200 base pair 
window generated from the H3K4me1 and H3K4me3 ChIP-seq experiment is 
depicted along with the normalised intensity of probes tiled across the same genomic 
region analysed during ChIP-chip experiments.  The signal intensity of the ChIP-chip 
tracks represents the intensity enrichment over the corresponding Input sample.  
Regions defined as enriched for H3K4me1 or H3K4me3 by SICER analysis, sites of 
DNase I hypersensitivity in AoSMCs, CpG islands and annotated Refseq transcripts 
are also displayed.  The red box signifies a region enriched for H3K4me1 in the ChIP-
seq studies and in two biological replicates analysed in the ChIP-chip studies. !
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Figure 5.2.25 - Classifying the location of SICER called regions of H3K27me3 
enrichment in relation to the closest gene – The 15,434 SICER defined regions of 
H3K27me3 enrichment were classified based upon their linear distance from the closest 
annotated gene in the RefSeq database using the GenomicAnnotation Tool in ChIPSeeqer 
2.0. Peaks were classified as those that overlapped with annotated TSSs (white segment), 
those that were located within an annotated gene (black segment), those that were greater 
than 3kb but less than 50kb from an annotated gene (dark grey segment) and those that 
were located greater than 50kb from an annotated gene (light grey segment).  The 
bracketed number indicates the number of H3K27me3 enrichments in each classification. 
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Figure 5.2.26 – Genes from which low levels of transcript are detected are more 
commonly associated with regions of H3K27me3 enrichment compared to genes 
from which high levels of transcript are detected – Loci that were associated with a 
SICER-defined region of H3K27me3 enrichment were determined using the 
GenomicAnnotation Tool in ChIPSeeqer.  These loci were compared to Affymetrix 
microarray expression data to determine the relationship between the abundance of a 
transcript and the presence of a H3K27me3 enrichment within that gene. 5 bins of 
Refseq transcripts were defined based upon expression levels, with Bin A containing 
the 1000 transcripts with the highest level of detection and subsequent bins of 1000 
transcripts were taken at 3000 data point intervals until Bin E, which contains the 
1000 transcripts with the lowest level of detection. The percentage of transcripts in 
each bin that were associated with a region of H3K27me3 enrichment was then 
calculated.  !
! LBI!
#O/77/;7/2/*.&.)#*P! !9/./7$)*&.)#*! #6! FW!%&.8D&<! /*7):8$/*.! (/$#*2.7&./(! .8&.!'/*/2! &:.)O/4<! 2)4/*:/(! )*! :,4.,7/(! ?+=32! D/7/! #O/77/;7/2/*./(! )*! ;&.8D&<2!)*O#4O/(! )*! (/O/4#;$/*.! &*(! .8/! 7/',4&.)#*! #6! 2)'*&4)*'! ;&.8D&<2P! ! C)',7/! BPLPLa!(/$#*2.7&./2!;&7.!#6!.8/!#,.;,.!'/*/7&./(!67#$!F/*/3#()2!&*(!)*():&./2!.8/!.#;!./*!;&.8D&<2! &22#:)&./(! D).8! '/*/2! (/$&7:&./(! D).8! G[0La$/[! &2! (/6)*/(! -<! .8/!*,$-/7! #6! '/*/2! 67#$! .8/! :#$;4/./! FW! X)#4#'):&4! %&.8D&<! &**#.&.)#*! )(/*.)6)/(P!!"8/2/! .#;! ./*! ;&.8D&<2! )*:4,(/(! $,4.):/44,4&7! #7'&*)2$&4! (/O/4#;$/*.A! 2)'*&4!.7&*2(,:.)#*A!7/',4&.)#*!#6!.7&*2:7);.)#*!&*(!:/44!()66/7/*.)&.)#*!MC)',7/!BPLPLa!M?NNP!!Y*!&(().)#*A!.8/!2.&.)2.):&4!&*&4<2)2!#6!.8/!#O/77/;7/2/*.&.)#*!#6!.8/!.#;!./*!;&.8D&<2!)2! 28#D*! MC)',7/! BPLPLa! MXNN! &*(! (/$#*2.7&./2! &! 8)'8! 4/O/4! #6! :#*6)(/*:/! )*! .8/!;&.8D&<!/*7):8$/*.P!
!
Figure 5.2.27 – GeneCodis 2.0 analysis indicates that loci demarcated with 
H3K27me3 in cultured ASMCs are primarily involved in development and the 
regulation of signaling pathways – The 1724 genes that were defined by SICER 
analysis as being associated with H3K27me3 across the body of the locus were used as 
an input list for GeneCodis 2.0.  The resulting output identifies pathways in which 
genes included in the input list are overrepresented.  A) Shows the top ten 
overrepresented pathways as determined by the number of genes in the input list 
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Figure 5.2.28 – H3K27me3 is enriched over the WIF1 but not the GNS or 
LEMD3 loci – A) The average level of detectable transcripts from all genes in 
cultured ASMCs was calculated from intensity values generated from Affymetrix 
U133.2 expression arrays.  The chart shows the mean expression of all genes and 
the relative expression of GNS, WIF-1, TBC1D20 and LEMD3.  FLJ41278 is not 
assayed on the Affymetrix U133.2 arrays.  B) H3K4me1, H3K4me3 and 
H3K27me3 aligned reads were uploaded to the UCSC genome browser as .bigwig 
files whilst regions determined by SICER to be enriched for each modification were 
uploaded as .bed files.  Annotated CpG islands, regions of DNase I hypersensitivity 
in aortic smooth muscle and RefSeq transcripts are shown for comparison.   !
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Figure 5.2.29 – An example of a broad region of intergenic H3K27me3 
enrichment between the RPP21 and HLA-E loci - H3K4me1, H3K4me3 and 
H3K27me3 aligned sequences were uploaded to the UCSC genome browser as 
.bigwig files whilst regions determined by SICER to be enriched for each modification 
were uploaded as .bed files.  Annotated CpG islands, regions of DNase I 
hypersensitivity in aortic smooth muscle and RefSeq transcripts are shown for 
comparison. The red box indicates a broad region of intergenic H3K27me3 
enrichment between regions of chromatin that are permissive for active transcription 






Figure 5.2.30 – An example of a focal intergenic enrichment of H3K27me3 between 
the DLG1 and BDH1 loci - H3K4me1, H3K4me3 and H3K27me3 aligned sequences 
were uploaded to the UCSC genome browser as .bigwig files whilst regions determined by 
SICER to be enriched for each modification were uploaded as .bed files.  Annotated CpG 
islands, regions of DNase I hypersensitivity in aortic smooth muscle and RefSeq 
transcripts are shown for comparison. The red box indicates a focal region of intergenic 
H3K27me3 enrichment between regions of chromatin that are permissive for active 
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ProbeSet Name H1  H2 H3 A1 A2  A3  Average  
hsa-miR-1826_st 13.19 12.98 13.66 13.71 13.42 13.71 13.44 
hsa-let-7b_st 13.45 13.54 13.36 13.55 13.23 13.29 13.40 
hsa-miR-638_st 12.88 12.34 13.12 12.63 13.55 13.56 13.01 
hsa-miR-923_st 12.80 12.68 13.00 12.92 12.40 12.71 12.75 
hsa-miR-125b_st 12.41 12.61 12.72 12.64 12.62 12.81 12.64 
hsa-let-7c_st 12.42 12.86 12.51 12.82 12.41 12.41 12.57 
hsa-miR-24_st 12.62 12.20 12.16 12.21 12.19 12.53 12.32 
hsa-miR-222_st 12.30 12.55 12.30 12.40 12.38 11.96 12.31 
hsa-miR-221_st 12.34 12.43 12.35 12.49 11.94 12.16 12.29 
hsa-miR-1228-
star_st 
12.03 11.96 12.42 12.02 12.94 12.31 12.28 
hsa-let-7a_st 12.05 12.38 11.98 12.35 12.12 12.29 12.20 
hsa-miR-23a_st 12.26 11.98 12.24 11.81 11.75 12.11 12.03 
hsa-miR-26a_st 11.87 11.86 11.85 12.03 11.56 11.70 11.81 
hsa-miR-663_st 11.00 11.11 11.52 11.49 12.16 11.66 11.49 
hsa-miR-149-
star_st 
11.02 11.15 11.56 11.16 12.47 11.57 11.49 
hsa-miR-145_st 11.27 11.68 11.37 11.79 11.17 11.54 11.47 
hsa-miR-23b_st 11.39 11.26 11.66 11.06 11.09 11.86 11.39 
hsa-miR-100_st 11.50 11.47 11.38 11.33 11.17 11.23 11.35 
hsa-miR-31_st 11.35 11.67 11.01 11.52 11.62 10.43 11.27 
hsa-miR-22_st 11.00 10.58 10.95 11.12 10.40 11.42 10.91 
hsa-miR-103_st 10.71 10.84 10.51 10.69 10.43 10.49 10.61 
hsa-miR-29a_st 10.86 10.64 10.54 10.39 10.26 10.85 10.59 
hsa-let-7e_st 10.56 10.96 10.64 10.45 10.25 10.58 10.57 
hsa-miR-107_st 10.51 10.55 10.29 10.43 10.48 10.25 10.42 
hsa-miR-16_st 10.26 10.37 10.35 10.31 10.40 10.20 10.32 
hsa-let-7d_st 10.27 10.57 10.25 10.48 9.82 10.28 10.28 
hsa-miR-199a-
5p_st 
10.38 10.34 10.11 10.25 9.99 10.01 10.18 
hsa-miR-1308_st 10.20 11.05 9.47 11.50 9.35 9.44 10.17 
hsa-miR-191_st 10.16 10.36 10.09 10.09 10.05 9.91 10.11 
hsa-miR-199b-
3p_st 
10.21 10.09 10.30 10.23 9.37 10.40 10.10 
hsa-miR-199a-
3p_st 
10.23 10.15 10.36 10.18 9.17 10.39 10.08 
hsa-miR-27a_st 10.53 10.08 9.83 9.61 9.58 10.61 10.04 
hsa-miR-125a-
5p_st 
10.08 10.42 9.97 9.83 9.94 9.83 10.01 
hsa-miR-494_st 9.40 9.84 10.12 10.96 9.69 9.76 9.96 
hsa-miR-320a_st 9.98 10.23 10.10 9.97 10.15 9.30 9.95 
hsa-miR-127-3p_st 9.54 10.23 9.77 10.76 9.68 9.67 9.94 
hsa-miR-320b_st 9.98 10.33 10.11 9.76 10.19 9.28 9.94 
hsa-let-7i_st 9.74 9.94 9.60 9.83 9.69 10.27 9.84 
hsa-miR-320c_st 9.75 10.01 9.87 9.78 9.79 9.25 9.74 
hsa-miR-143_st 9.56 9.52 9.37 9.84 9.08 10.47 9.64 
hsa-miR-193b_st 9.50 10.05 9.51 10.08 9.28 9.06 9.58 
hsa-miR-151-5p_st 9.57 9.68 9.49 9.57 9.58 9.32 9.54 
hsa-miR-99a_st 9.19 9.39 9.53 9.26 9.49 9.50 9.39 
hsa-miR-214_st 9.28 9.69 9.33 9.07 9.60 8.87 9.31 
! [c[!
hsa-miR-34a_st 9.69 9.06 9.02 9.40 8.81 9.46 9.24 
hsa-miR-574-3p_st 8.90 9.73 9.27 9.42 8.92 8.83 9.18 
hsa-miR-99b_st 9.22 9.13 9.11 9.34 8.92 8.84 9.09 
hsa-miR-768-5p_st 8.62 8.87 8.77 9.58 8.37 8.84 8.84 
hsa-miR-92a_st 9.25 9.12 8.56 8.63 9.14 8.25 8.82 
hsa-miR-181a_st 9.05 9.15 8.21 8.96 8.56 8.95 8.81 
hsa-miR-361-5p_st 9.26 8.85 9.03 8.51 8.48 8.57 8.78 
hsa-miR-138_st 9.55 9.74 7.54 8.73 8.04 8.37 8.66 
hsa-miR-93_st 9.10 9.19 8.42 8.35 8.29 7.98 8.56 
hsa-miR-768-3p_st 7.94 7.85 8.82 9.02 8.36 9.24 8.54 
hsa-miR-27b_st 8.45 8.57 8.63 8.46 7.60 9.41 8.52 
hsa-miR-320d_st 8.44 8.69 8.73 8.51 8.34 8.32 8.51 
hsa-miR-155_st 9.29 9.48 8.47 8.07 8.06 7.23 8.43 
hsa-miR-409-3p_st 8.64 8.54 8.15 8.74 8.26 8.05 8.40 
hsa-miR-1268_st 7.74 8.19 8.77 7.94 8.67 8.81 8.35 
hsa-miR-30c_st 8.03 8.44 8.59 8.11 8.14 8.57 8.31 
hsa-miR-342-3p_st 7.89 8.60 8.04 8.61 8.07 8.09 8.22 
hsa-miR-423-3p_st 8.25 8.46 8.00 8.21 8.41 7.91 8.21 
hsa-miR-1207-
5p_st 
7.65 8.48 8.49 8.05 8.37 8.17 8.20 
hsa-miR-92b-
star_st 
7.83 7.91 8.64 7.82 8.16 8.34 8.12 
hsa-miR-15b_st 7.69 8.44 8.22 8.40 8.34 7.40 8.08 
hsa-miR-17_st 8.91 8.11 8.15 7.27 8.18 7.53 8.02 
hsa-miR-1231_st 7.77 7.65 8.73 7.67 8.37 7.83 8.00 
hsa-miR-185_st 8.35 7.91 7.64 8.04 7.72 8.33 8.00 
hsa-miR-455-3p_st 8.30 8.49 8.27 7.87 7.24 7.81 8.00 
hsa-miR-152_st 8.18 7.83 7.84 8.13 7.18 8.52 7.95 
hsa-let-7f_st 7.61 8.07 7.80 8.20 7.34 8.42 7.91 
hsa-miR-106a_st 8.65 8.05 8.02 7.15 7.88 7.34 7.85 
hsa-miR-487b_st 7.89 7.82 7.48 8.36 7.46 7.94 7.82 
hsa-miR-708_st 7.50 8.16 7.79 7.70 7.94 7.85 7.82 
hsa-miR-134_st 7.83 8.26 7.71 8.57 7.28 7.04 7.78 
hsa-miR-193a-
5p_st 
7.96 7.94 7.76 7.44 8.04 7.09 7.70 
hsa-miR-130a_st 7.80 7.27 7.86 7.45 7.52 8.04 7.66 
hsa-miR-30a_st 7.78 7.43 7.32 7.27 7.33 8.51 7.61 
hsa-miR-181b_st 7.94 7.81 7.30 7.34 7.33 7.53 7.54 
hsa-miR-432_st 7.57 7.87 7.57 8.22 6.72 7.30 7.54 
hsa-miR-379_st 7.71 7.94 6.87 8.33 7.11 7.12 7.51 
hsa-miR-1307_st 7.49 7.31 7.91 7.37 7.33 7.54 7.49 
hsa-miR-10a_st 7.26 7.35 7.65 7.80 6.79 7.65 7.41 
hsa-miR-20a_st 8.58 7.51 7.37 6.57 7.40 6.91 7.39 
hsa-miR-106b_st 8.10 7.07 7.45 6.95 7.08 7.49 7.36 
hsa-miR-140-3p_st 7.67 7.17 7.91 6.78 7.45 7.09 7.34 
hsa-miR-744_st 7.10 7.17 7.47 6.97 7.90 7.00 7.27 
hsa-miR-503_st 8.08 7.49 7.17 6.45 7.10 7.32 7.27 
hsa-miR-19b_st 7.92 6.51 7.47 7.20 6.97 7.50 7.26 
hsa-miR-21_st 7.42 7.08 6.82 7.41 6.48 8.20 7.24 
hsa-miR-1280_st 6.99 7.35 6.51 6.93 8.09 7.32 7.20 
hsa-miR-130b_st 7.51 7.44 7.08 7.25 7.09 6.45 7.14 
hsa-miR-720_st 6.78 7.00 6.73 7.16 7.83 7.30 7.13 
hsa-miR-382_st 6.95 7.38 6.88 8.07 6.53 6.96 7.13 
hsa-miR-138-1-
star_st 
7.34 8.01 6.61 7.54 6.49 6.38 7.06 
! [c_!
hsa-miR-425_st 7.17 7.33 7.06 7.08 6.65 7.05 7.06 
hsa-miR-151-3p_st 7.12 7.24 6.92 7.28 6.85 6.93 7.05 
hsa-miR-197_st 6.96 8.03 6.76 7.40 6.72 6.41 7.05 
hsa-miR-210_st 6.75 7.58 6.71 6.62 7.08 7.51 7.04 
hsa-miR-30d_st 6.99 7.04 6.75 7.16 6.73 7.53 7.03 
hsa-miR-346_st 6.67 6.54 7.16 6.90 7.51 7.12 6.98 
hsa-let-7g_st 6.98 7.18 6.77 7.36 6.23 7.21 6.96 
hsa-miR-1225-
5p_st 
6.65 7.01 6.68 6.39 8.19 6.71 6.94 
hsa-miR-30b_st 6.51 6.84 7.07 6.99 7.12 7.08 6.94 
hsa-miR-886-5p_st 7.15 7.19 6.81 6.20 7.19 6.88 6.90 
hsa-miR-28-5p_st 7.04 7.19 7.00 7.18 5.95 7.05 6.90 
hsa-miR-25_st 6.85 7.13 6.84 7.03 6.47 6.80 6.85 
hsa-miR-149_st 6.77 7.22 7.05 7.37 6.37 6.31 6.85 
hsa-miR-324-3p_st 6.47 6.91 6.43 7.39 6.46 6.49 6.69 
hsa-miR-132_st 6.61 7.04 6.74 6.60 6.15 6.64 6.63 
hsa-miR-195_st 6.48 6.39 7.05 6.19 6.55 7.12 6.63 
hsa-miR-424-
star_st 
6.98 7.34 6.53 6.25 6.70 5.94 6.62 
hsa-miR-324-5p_st 6.87 6.86 5.85 6.99 6.51 6.57 6.61 
hsa-miR-612_st 7.14 6.72 6.23 7.54 6.20 5.42 6.54 
hsa-miR-1246_st 6.74 6.18 6.74 5.65 6.72 7.16 6.53 
hsa-miR-502-3p_st 6.65 7.22 6.25 7.08 5.85 6.14 6.53 
hsa-miR-574-5p_st 6.37 7.04 6.49 6.43 6.37 6.42 6.52 
hsa-miR-423-5p_st 6.83 6.78 6.30 6.26 6.41 6.28 6.48 
hsa-miR-654-3p_st 6.32 6.95 6.46 7.24 5.44 6.43 6.47 
hsa-miR-885-3p_st 6.26 6.37 6.37 5.95 6.85 6.87 6.45 
hsa-miR-125b-1-
star_st 
6.50 7.04 6.71 6.13 6.05 5.93 6.39 
hsa-miR-409-5p_st 6.85 6.64 6.27 7.09 5.12 6.37 6.39 
hsa-miR-337-5p_st 6.24 5.98 6.46 6.59 6.05 6.69 6.34 
hsa-miR-92b_st 6.22 6.49 6.37 6.29 6.47 6.09 6.32 
hsa-miR-874_st 5.99 6.04 6.29 6.38 6.52 6.70 6.32 
hsa-miR-500-
star_st 
6.06 6.69 6.13 7.10 5.61 6.06 6.27 
hsa-miR-943_st 6.04 6.00 6.46 6.18 6.42 6.21 6.22 
hsa-miR-378_st 6.63 6.51 5.40 6.90 6.05 5.79 6.21 
hsa-miR-493_st 6.31 6.75 5.81 6.55 5.59 6.17 6.20 
hsa-miR-532-3p_st 6.20 6.61 5.80 6.48 5.74 6.25 6.18 
hsa-miR-30a-
star_st 
6.52 6.19 6.33 6.58 5.15 6.30 6.18 
hsa-miR-532-5p_st 6.48 5.80 6.14 6.58 5.90 5.98 6.15 
hsa-miR-370_st 6.36 6.23 5.75 7.16 5.91 5.36 6.13 
hsa-miR-28-3p_st 5.94 6.69 6.31 6.00 5.25 6.56 6.13 
hsa-miR-885-5p_st 5.36 5.90 6.23 6.17 6.60 6.40 6.11 
hsa-miR-1275_st 6.11 6.03 6.21 6.23 6.02 5.86 6.08 
hsa-miR-1271_st 5.42 6.45 6.17 6.48 5.91 5.90 6.06 
hsa-miR-362-5p_st 6.22 6.70 6.24 6.33 5.34 5.50 6.05 
hsa-miR-125b-2-
star_st 
5.70 6.41 6.13 6.55 5.69 5.66 6.02 
hsa-miR-146b-
5p_st 
6.04 6.38 6.69 6.10 4.93 5.88 6.00 
hsa-miR-1281_st 5.85 5.84 6.04 6.11 5.36 6.77 5.99 
hsa-miR-345_st 6.07 6.61 5.65 5.77 6.06 5.62 5.97 
hsa-miR-339-5p_st 6.57 6.31 5.94 5.18 6.15 5.63 5.96 
hsa-miR-411_st 5.89 6.10 5.71 6.61 5.17 6.12 5.94 
hsa-miR-425- 5.86 5.81 6.30 5.63 5.75 6.25 5.94 
! [cB!
star_st 
hsa-miR-335_st 5.26 5.24 5.34 6.20 7.55 6.00 5.94 
hsa-miR-671-5p_st 5.99 6.33 5.86 5.61 6.10 5.69 5.93 
hsa-miR-132-
star_st 
5.61 5.80 5.76 5.73 6.96 5.70 5.93 
hsa-miR-939_st 5.25 5.35 6.61 5.88 6.09 6.32 5.92 
hsa-miR-299-5p_st 5.95 6.04 6.12 6.49 5.11 5.40 5.85 
hsa-miR-328_st 5.92 5.71 5.65 5.68 6.08 5.88 5.82 
hsa-miR-500_st 6.42 5.98 5.77 6.02 5.07 5.59 5.81 
hsa-miR-675_st 5.48 6.68 6.04 6.09 6.03 4.52 5.81 
hsa-miR-376c_st 5.54 5.96 5.75 6.34 5.17 5.97 5.79 
hsa-miR-181a-
star_st 
5.31 4.48 5.91 5.86 7.13 5.93 5.77 
hsa-miR-181c-
star_st 
5.49 5.64 4.28 6.06 6.70 6.40 5.76 
hsa-miR-191-
star_st 
5.76 5.51 5.81 5.83 5.72 5.91 5.76 
hsa-miR-625_st 5.58 6.23 6.01 5.40 5.57 5.73 5.75 
hsa-miR-1237_st 5.87 5.57 5.82 5.55 5.83 5.65 5.71 
hsa-miR-18a_st 7.22 4.73 5.48 5.47 5.96 5.39 5.71 
hsa-miR-15a_st 6.53 5.01 5.65 5.48 5.40 6.06 5.69 
hsa-miR-501-3p_st 4.88 6.27 5.14 6.22 5.78 5.80 5.68 
hsa-miR-1260_st 5.56 5.71 5.45 5.85 5.91 5.60 5.68 
hsa-miR-886-3p_st 5.97 5.34 5.79 4.42 5.95 6.43 5.65 
hsa-miR-665_st 5.38 5.61 5.59 6.03 5.71 5.56 5.65 
hsa-miR-24-2-
star_st 
6.50 5.52 5.68 5.82 4.34 5.93 5.63 
hsa-miR-1274b_st 4.46 5.78 5.20 5.86 6.19 6.00 5.58 
hsa-miR-491-5p_st 6.13 5.38 5.35 5.50 5.81 5.31 5.58 
hsa-miR-484_st 5.86 5.83 5.09 5.59 5.29 5.46 5.52 
hsa-miR-596_st 5.18 4.86 5.86 5.75 5.28 6.05 5.49 
hsa-miR-602_st 4.75 5.15 6.03 5.24 5.91 5.79 5.48 
hsa-miR-1228_st 5.44 5.50 5.47 5.61 5.51 5.32 5.48 
hsa-miR-299-3p_st 5.58 5.33 4.83 6.03 5.66 5.38 5.47 
hsa-miR-296-5p_st 5.30 5.84 5.47 5.29 5.89 4.98 5.46 
hsa-miR-29b-1-
star_st 
5.96 5.58 5.66 5.81 4.21 5.42 5.44 
hsa-miR-154_st 4.53 5.36 5.60 6.52 5.01 5.61 5.44 
hsa-miR-99b-
star_st 
5.83 5.67 5.49 5.38 5.15 5.08 5.43 
hsa-miR-505-
star_st 
5.81 5.66 5.21 5.44 5.20 5.11 5.41 
hsa-miR-146a_st 5.42 6.00 6.62 5.58 4.79 4.02 5.40 
hsa-miR-490-5p_st 5.84 5.15 5.54 6.14 4.18 5.54 5.40 
hsa-miR-93-star_st 5.60 5.65 5.32 5.23 5.35 5.05 5.37 
hsa-miR-431_st 5.61 5.01 5.10 5.79 5.14 5.51 5.36 
hsa-miR-615-5p_st 5.09 5.26 5.64 5.47 5.02 5.61 5.35 
hsa-miR-572_st 4.96 4.16 6.01 5.23 5.43 6.24 5.34 
hsa-miR-331-3p_st 5.27 5.66 5.29 5.11 5.21 5.43 5.33 
hsa-miR-497_st 5.06 5.48 5.91 5.12 5.13 5.27 5.33 
hsa-miR-199b-
5p_st 
5.43 5.22 5.56 5.60 4.74 5.41 5.33 
hsa-miR-34c-5p_st 5.83 5.33 5.40 5.45 4.67 5.21 5.31 
hsa-miR-150-
star_st 
5.61 5.36 5.65 5.17 4.86 5.11 5.29 
hsa-miR-485-3p_st 5.07 5.45 5.34 5.68 4.78 5.33 5.28 
hsa-miR-495_st 4.92 4.87 5.37 5.73 5.22 5.45 5.26 




4.66 5.99 4.79 5.41 5.39 5.27 5.25 
hsa-miR-187-
star_st 
5.13 4.84 5.39 5.23 5.51 5.35 5.24 
hsa-miR-625-
star_st 
5.14 5.41 5.48 5.08 5.21 5.11 5.24 
hsa-miR-933_st 4.75 4.91 5.53 5.71 5.18 5.31 5.23 
hsa-miR-636_st 4.90 5.03 5.15 5.59 5.54 5.16 5.23 
hsa-miR-1249_st 5.52 5.68 5.17 5.03 5.21 4.74 5.22 
hsa-miR-940_st 5.72 4.97 4.65 5.24 5.64 5.10 5.22 
hsa-miR-877_st 5.23 5.53 5.35 5.15 5.00 5.04 5.22 
hsa-miR-1238_st 4.82 5.30 5.45 5.36 4.93 5.34 5.20 
hsa-miR-543_st 5.22 5.16 5.13 5.51 4.43 5.76 5.20 
hsa-miR-193a-
3p_st 
4.96 5.12 5.20 5.46 4.94 5.24 5.15 
hsa-miR-106b-
star_st 
4.89 5.44 4.97 5.05 5.13 5.31 5.13 
hsa-miR-22-star_st 5.28 4.77 5.25 4.95 4.69 5.71 5.11 
hsa-miR-652_st 4.43 5.77 5.32 5.41 5.17 4.53 5.11 
hsa-miR-1244_st 4.62 5.25 4.78 5.99 5.16 4.80 5.10 
hsa-miR-1202_st 4.55 4.72 5.61 5.66 4.42 5.58 5.09 
hsa-miR-654-5p_st 5.20 5.26 4.67 5.34 4.98 4.94 5.07 
hsa-miR-127-5p_st 5.18 4.81 4.37 5.52 5.32 5.18 5.06 
hsa-miR-129-
star_st 
4.24 4.53 5.02 4.85 5.72 5.97 5.06 
hsa-miR-487a_st 5.22 5.36 4.32 5.19 4.76 5.42 5.04 
hsa-miR-498_st 4.87 5.09 4.75 5.12 5.50 4.93 5.04 
hsa-miR-329_st 4.38 4.76 5.26 6.04 4.55 5.25 5.04 
hsa-miR-125a-
3p_st 
5.43 5.16 4.62 5.27 4.86 4.89 5.04 
hsa-miR-542-5p_st 5.28 5.17 4.86 4.90 5.00 4.96 5.03 
hsa-miR-576-3p_st 3.85 4.40 4.22 4.65 7.01 6.02 5.02 
hsa-miR-129-3p_st 5.09 4.73 4.77 4.26 5.87 5.38 5.02 
hsa-miR-34c-3p_st 5.11 5.65 4.96 4.78 4.64 4.89 5.00 
hsa-miR-20b_st 5.49 5.01 5.17 4.78 4.46 5.06 5.00 
hsa-miR-483-5p_st 4.78 4.91 5.14 4.73 5.01 5.39 4.99 
hsa-miR-25-star_st 4.43 5.73 4.77 5.28 4.94 4.77 4.99 
hsa-miR-769-5p_st 4.79 4.54 4.89 5.39 5.10 5.17 4.98 
hsa-miR-1234_st 5.30 4.70 5.04 5.35 4.72 4.72 4.97 
hsa-miR-381_st 5.16 4.15 4.91 5.37 4.69 5.51 4.96 
hsa-miR-214-
star_st 
4.64 4.69 5.41 5.17 4.77 4.96 4.94 
hsa-miR-935_st 4.65 4.42 5.43 5.16 4.51 5.36 4.92 
hsa-miR-1227_st 4.85 5.42 4.96 5.07 4.67 4.54 4.92 
hsa-miR-490-3p_st 5.07 4.64 5.11 5.42 3.85 5.39 4.91 
hsa-miR-361-3p_st 5.01 4.81 4.91 5.09 4.74 4.89 4.91 
hsa-miR-181d_st 4.99 4.83 4.95 4.51 4.48 5.66 4.90 
hsa-miR-330-3p_st 4.50 4.79 5.17 4.94 5.00 5.02 4.90 
hsa-miR-31-star_st 6.05 5.28 4.90 3.98 4.38 4.76 4.89 
hsa-miR-193b-
star_st 
4.85 4.46 4.91 5.05 5.10 4.95 4.89 
hsa-let-7d-star_st 4.49 4.62 5.03 5.24 4.99 4.84 4.87 
hsa-miR-29b-2-
star_st 
4.96 4.62 4.94 5.38 4.13 5.08 4.85 
hsa-miR-1825_st 4.67 5.00 4.63 4.96 4.82 5.00 4.85 
hsa-miR-198_st 4.73 4.45 5.29 4.81 4.56 5.24 4.85 
hsa-miR-377-
star_st 
4.48 5.01 5.04 5.69 3.98 4.86 4.84 
hsa-miR-1225- 5.16 5.10 4.59 4.51 5.17 4.49 4.84 
! [ca!
3p_st 
hsa-miR-606_st 4.19 4.45 4.38 4.46 6.00 5.31 4.80 
hsa-miR-433_st 4.38 4.57 4.62 5.43 4.71 5.03 4.79 
hsa-miR-373-
star_st 
3.95 5.27 5.64 4.86 4.15 4.88 4.79 
hsa-miR-128_st 4.46 4.07 5.25 4.80 4.96 5.17 4.78 
hsa-miR-637_st 4.74 4.32 4.54 5.11 4.56 5.42 4.78 
hsa-miR-339-3p_st 4.85 5.32 4.69 4.35 4.20 5.23 4.77 
hsa-let-7b-star_st 4.59 4.01 4.83 4.83 5.23 5.09 4.76 
hsa-miR-29c_st 5.30 3.85 4.59 4.47 4.52 5.75 4.75 
hsa-miR-1180_st 4.96 5.05 4.95 4.64 4.35 4.46 4.73 
hsa-miR-411-
star_st 
4.89 4.77 4.47 4.59 4.40 5.20 4.72 
hsa-miR-30e_st 4.28 3.78 4.52 4.55 5.40 5.74 4.71 
hsa-miR-1301_st 5.33 4.27 4.70 4.45 4.62 4.89 4.71 
hsa-miR-374a-
star_st 
4.02 4.57 4.08 4.64 5.94 4.98 4.70 
hsa-miR-1184_st 4.28 5.17 4.68 4.80 4.75 4.51 4.70 
hsa-miR-421_st 5.12 4.59 4.52 4.94 4.03 4.96 4.69 
hsa-miR-376a_st 4.77 4.18 4.70 5.05 4.76 4.63 4.68 
hsa-miR-1267_st 4.77 4.72 4.26 4.81 4.70 4.79 4.67 
hsa-miR-181c_st 4.68 4.25 4.53 4.45 4.99 5.14 4.67 
hsa-miR-34a-
star_st 
4.24 4.15 4.91 5.05 4.46 5.14 4.66 
hsa-miR-1224-
3p_st 
5.03 4.43 4.48 4.61 4.95 4.44 4.66 
hsa-miR-221-
star_st 
4.46 4.88 4.83 4.68 4.04 5.02 4.65 
hsa-miR-483-3p_st 5.07 3.94 4.94 4.76 4.85 4.29 4.64 
hsa-miR-1287_st 5.13 4.73 4.42 4.89 4.07 4.51 4.63 
hsa-miR-877-
star_st 
4.72 5.00 4.42 4.73 4.41 4.42 4.62 
hsa-miR-21-star_st 5.46 4.26 4.41 4.58 4.42 4.56 4.62 
hsa-miR-1296_st 4.55 4.39 4.95 4.06 5.02 4.71 4.61 
hsa-miR-634_st 4.49 4.37 4.37 5.00 4.88 4.54 4.61 
hsa-miR-493-
star_st 
3.79 4.70 4.29 5.33 4.37 5.12 4.60 
hsa-miR-1224-
5p_st 
4.79 4.45 4.17 4.49 4.55 5.06 4.59 
hsa-miR-135a-
star_st 
4.14 4.45 4.56 4.62 4.87 4.88 4.59 
hsa-miR-212_st 4.78 5.03 4.17 4.71 4.20 4.62 4.58 
hsa-miR-365_st 4.25 4.09 4.49 3.98 5.44 5.24 4.58 
hsa-miR-1236_st 4.75 4.75 4.41 4.55 5.01 4.02 4.58 
hsa-miR-7-2-star_st 4.36 4.56 4.52 4.52 4.76 4.74 4.58 
hsa-miR-194_st 4.65 4.92 4.64 4.01 4.05 5.19 4.58 
hsa-miR-660_st 4.72 4.26 5.30 4.52 3.91 4.75 4.58 
hsa-miR-559_st 4.40 4.40 4.14 3.99 5.44 5.08 4.58 
hsa-miR-584_st 4.73 4.78 5.32 4.24 3.92 4.44 4.57 
hsa-miR-664_st 4.97 4.80 4.62 4.34 4.51 4.19 4.57 
hsa-miR-921_st 4.14 4.68 4.77 4.36 4.79 4.67 4.57 
hsa-miR-371-5p_st 4.22 4.34 4.42 4.35 5.02 5.00 4.56 
hsa-miR-27b-
star_st 
4.35 4.70 5.07 4.21 4.26 4.72 4.55 
hsa-miR-30c-2-
star_st 
4.46 4.20 4.95 5.18 3.73 4.77 4.55 
hsa-miR-1233_st 4.37 4.69 4.39 4.46 4.89 4.48 4.55 
hsa-miR-29b_st 5.92 3.95 4.46 4.22 4.29 4.41 4.54 
hsa-miR-140-5p_st 5.07 3.99 4.64 4.46 4.49 4.60 4.54 
! [cb!
hsa-miR-659_st 4.51 4.60 4.61 4.71 4.03 4.78 4.54 
hsa-miR-34b_st 4.39 3.82 4.36 5.06 4.89 4.69 4.53 
hsa-miR-98_st 3.90 4.74 4.63 4.55 4.50 4.88 4.53 
hsa-miR-668_st 4.85 3.91 4.73 4.54 4.40 4.73 4.52 
hsa-miR-505_st 4.45 5.52 4.39 4.12 4.27 4.40 4.52 
hsa-miR-1229_st 4.94 5.34 4.59 3.50 4.34 4.39 4.52 
hsa-miR-501-5p_st 4.79 4.16 4.27 4.85 4.32 4.69 4.52 
hsa-miR-589-
star_st 
4.55 4.61 4.34 5.00 4.46 4.13 4.51 
hsa-miR-1300_st 4.00 4.97 4.47 4.26 4.81 4.57 4.51 
hsa-miR-422a_st 4.04 5.02 4.06 5.03 4.06 4.82 4.50 
hsa-miR-1288_st 4.06 4.91 4.15 4.12 4.78 4.89 4.49 
hsa-miR-1181_st 3.93 4.82 4.47 4.72 4.69 4.27 4.49 
hsa-miR-504_st 4.49 4.58 4.70 4.47 4.37 4.15 4.46 
hsa-miR-223_st 4.62 4.54 4.47 4.34 4.46 4.33 4.46 
hsa-miR-454-
star_st 
3.95 4.45 3.72 4.33 5.75 4.54 4.46 
hsa-miR-548e_st 3.78 4.11 3.86 3.95 5.80 5.19 4.45 
hsa-miR-664-
star_st 
3.78 4.36 4.76 4.33 4.30 5.17 4.45 
hsa-miR-338-5p_st 4.54 4.73 4.28 4.33 4.48 4.26 4.44 
hsa-miR-129-5p_st 4.37 5.01 4.13 3.93 4.45 4.64 4.42 
hsa-miR-296-3p_st 4.44 4.44 4.62 4.29 4.25 4.45 4.42 
hsa-miR-148b_st 4.41 4.17 4.44 4.43 4.16 4.88 4.42 
hsa-miR-539_st 4.82 4.18 4.14 4.56 4.46 4.31 4.41 
hsa-miR-595_st 4.02 4.66 4.15 4.31 4.73 4.60 4.41 
hsa-miR-17-star_st 4.80 4.71 4.49 4.21 4.10 4.14 4.41 
hsa-miR-548f_st 3.89 4.27 4.08 4.00 5.24 4.90 4.40 
hsa-miR-1274a_st 3.70 4.51 3.99 4.61 4.54 4.99 4.39 
hsa-miR-758_st 4.77 4.51 4.39 4.46 3.59 4.62 4.39 
hsa-miR-766_st 4.56 4.61 3.86 4.26 4.67 4.38 4.39 
hsa-miR-133a_st 4.93 4.15 4.25 4.25 4.55 4.20 4.39 
hsa-miR-1247_st 4.74 4.41 4.59 4.88 3.84 3.82 4.38 
hsa-miR-424_st 4.21 4.36 4.36 4.31 4.40 4.63 4.38 
hsa-miR-802_st 4.49 4.27 4.29 4.33 4.84 4.03 4.38 
hsa-miR-887_st 4.83 4.64 4.30 4.01 4.09 4.37 4.37 
hsa-let-7f-1-star_st 4.07 4.26 4.74 4.76 3.96 4.42 4.37 
hsa-miR-629_st 4.80 3.89 3.87 4.64 4.63 4.38 4.37 
hsa-miR-513a-
5p_st 
4.76 4.16 4.11 4.29 4.49 4.36 4.36 
hsa-miR-492_st 4.34 4.31 4.28 4.52 4.44 4.28 4.36 
hsa-miR-769-3p_st 4.58 5.27 3.75 4.27 4.01 4.29 4.36 
hsa-miR-133b_st 4.03 4.69 4.55 4.48 4.35 4.07 4.36 
hsa-miR-342-5p_st 4.18 4.58 4.35 4.43 3.90 4.72 4.36 
hsa-miR-563_st 4.25 5.09 4.42 3.93 4.15 4.30 4.36 
hsa-miR-18b-
star_st 
4.17 4.49 4.43 4.29 4.69 4.03 4.35 
hsa-miR-564_st 4.38 4.29 4.59 4.69 4.10 4.04 4.35 
hsa-miR-1254_st 4.47 4.58 4.76 3.76 4.44 4.07 4.35 
hsa-miR-486-5p_st 3.95 4.70 4.66 4.29 4.10 4.38 4.35 
hsa-let-7e-star_st 4.25 4.25 4.18 4.37 4.64 4.28 4.33 
hsa-miR-208a_st 3.92 3.99 4.00 4.00 5.40 4.65 4.32 
hsa-miR-548c-
3p_st 
4.10 4.10 4.08 4.19 4.59 4.85 4.32 
hsa-miR-629-
star_st 
4.13 4.34 4.22 4.17 4.26 4.78 4.32 
hsa-miR-615-3p_st 4.40 4.04 4.39 4.80 4.31 3.92 4.31 
! [cJ!
hsa-miR-208b_st 4.22 4.13 4.30 4.07 4.56 4.58 4.31 
hsa-miR-30c-1-
star_st 
4.16 4.11 4.17 4.43 4.29 4.63 4.30 
hsa-miR-551b-
star_st 
4.37 4.14 4.30 4.58 4.25 4.10 4.29 
hsa-miR-623_st 3.97 4.20 4.36 4.61 4.21 4.35 4.28 
hsa-miR-744-
star_st 
4.30 4.63 4.14 4.38 4.12 4.10 4.28 
hsa-miR-1183_st 4.49 4.40 4.19 4.58 3.92 4.09 4.28 
hsa-miR-627_st 4.11 3.86 4.18 4.08 4.92 4.52 4.28 
hsa-miR-517-
star_st 
4.57 4.21 4.14 3.95 4.61 4.15 4.27 
hsa-miR-628-3p_st 4.05 4.08 4.58 4.17 4.02 4.73 4.27 
hsa-miR-1273_st 4.59 4.36 4.09 4.27 4.14 4.16 4.27 
hsa-miR-126_st 4.48 4.08 4.30 4.36 3.69 4.68 4.27 
hsa-miR-888_st 3.73 4.31 3.67 3.77 5.18 4.90 4.26 
hsa-miR-557_st 3.55 3.77 4.54 4.69 4.73 4.28 4.26 
hsa-miR-550-
star_st 
4.26 4.34 4.28 4.32 3.98 4.38 4.26 
hsa-miR-326_st 4.02 4.22 4.54 4.28 4.06 4.43 4.26 
hsa-miR-1285_st 4.02 4.37 4.43 4.34 3.75 4.62 4.26 
hsa-miR-518b_st 4.45 4.50 4.09 4.49 3.90 4.11 4.26 
hsa-miR-27a-
star_st 
4.29 4.17 4.56 4.66 4.08 3.75 4.25 
hsa-miR-938_st 4.22 4.74 4.11 4.16 4.22 4.05 4.25 
hsa-miR-26b_st 4.32 4.40 4.19 4.61 3.68 4.23 4.24 
hsa-miR-374b_st 3.95 4.32 4.36 4.33 4.21 4.26 4.24 
hsa-miR-1293_st 4.33 3.79 4.31 4.06 4.55 4.40 4.24 
hsa-miR-143-
star_st 
3.50 4.95 3.98 4.79 3.51 4.67 4.23 
hsa-miR-641_st 4.28 4.49 4.15 4.35 4.03 4.10 4.23 
hsa-miR-1303_st 3.82 4.26 3.75 4.38 4.80 4.38 4.23 
hsa-miR-633_st 4.38 4.18 4.11 4.07 4.66 3.97 4.23 
hsa-miR-30e-
star_st 
3.89 3.81 4.02 4.99 3.90 4.74 4.22 
hsa-miR-23b-
star_st 
4.48 4.14 4.09 3.93 3.96 4.76 4.22 
hsa-miR-10b_st 4.15 3.88 4.48 4.25 4.19 4.40 4.22 
hsa-miR-188-5p_st 4.31 4.30 3.90 4.34 4.24 4.24 4.22 
hsa-miR-323-3p_st 3.83 4.63 3.61 4.47 4.37 4.37 4.21 
hsa-miR-605_st 4.42 4.10 4.00 4.58 4.22 3.92 4.21 
hsa-miR-1255a_st 3.95 3.94 4.06 4.06 4.94 4.27 4.20 
hsa-miR-548p_st 4.22 3.91 4.28 4.22 4.57 4.03 4.20 
hsa-miR-10a-
star_st 
4.05 3.93 4.23 4.60 3.89 4.50 4.20 
hsa-miR-220a_st 4.31 4.26 3.91 4.03 4.44 4.22 4.20 
hsa-miR-1272_st 4.15 4.26 4.28 4.25 4.16 4.07 4.19 
hsa-miR-582-3p_st 4.32 4.15 4.29 4.25 4.07 4.08 4.19 
hsa-miR-1290_st 3.85 4.14 4.13 3.95 4.13 4.95 4.19 
hsa-miR-337-3p_st 3.86 4.66 4.16 4.24 3.95 4.29 4.19 
hsa-miR-148a_st 4.19 4.07 4.07 3.68 4.66 4.46 4.19 
hsa-miR-130b-
star_st 
4.41 3.92 4.35 3.95 4.26 4.23 4.19 
hsa-miR-513b_st 4.05 3.78 4.79 4.30 4.10 4.09 4.19 
hsa-miR-378-
star_st 
4.68 4.17 3.97 4.24 3.86 4.20 4.19 
hsa-miR-219-1-
3p_st 
4.16 4.68 3.92 4.19 3.75 4.42 4.19 
hsa-miR-195-
star_st 
4.04 4.30 4.30 4.19 4.32 3.94 4.18 
! [Ic!
hsa-miR-1323_st 4.12 4.63 3.95 4.11 4.11 4.16 4.18 
hsa-miR-489_st 4.31 4.28 4.06 4.41 4.09 3.92 4.18 
hsa-miR-541-
star_st 
3.65 3.82 4.67 4.42 4.03 4.47 4.18 
hsa-miR-29c-
star_st 
4.13 4.45 4.44 4.11 3.88 4.01 4.17 
hsa-miR-583_st 4.57 3.93 3.97 4.31 4.15 4.09 4.17 
hsa-miR-1262_st 4.13 4.08 4.16 4.14 4.34 4.13 4.16 
hsa-miR-1258_st 3.95 4.18 4.11 4.43 4.11 4.20 4.16 
hsa-miR-454_st 4.35 3.96 3.94 4.01 4.26 4.46 4.16 
hsa-miR-626_st 4.15 4.52 4.08 3.99 4.06 4.17 4.16 
hsa-miR-1208_st 3.76 4.38 4.15 4.18 4.63 3.87 4.16 
hsa-miR-196a-
star_st 
4.48 4.02 3.73 4.18 4.22 4.31 4.16 
hsa-miR-635_st 4.66 4.08 4.14 4.36 3.78 3.91 4.16 
hsa-miR-765_st 4.21 3.94 4.57 3.98 4.05 4.18 4.15 
hsa-miR-224_st 4.30 4.21 4.05 4.06 4.21 4.08 4.15 
hsa-miR-137_st 4.37 3.93 3.83 4.16 4.24 4.35 4.15 
hsa-miR-222-
star_st 
3.90 4.29 4.20 4.11 4.00 4.38 4.15 
hsa-miR-506_st 4.23 4.04 4.40 3.60 4.11 4.48 4.14 
hsa-miR-335-
star_st 
4.13 3.85 4.25 4.34 4.04 4.23 4.14 
hsa-miR-920_st 3.83 4.13 4.51 3.92 4.26 4.19 4.14 
hsa-miR-671-3p_st 4.60 4.38 3.83 3.95 4.35 3.71 4.14 
hsa-miR-204_st 4.02 4.13 4.18 4.11 4.24 4.13 4.13 
hsa-miR-520b_st 4.20 4.49 4.32 4.49 3.38 3.93 4.13 
hsa-miR-508-3p_st 3.93 4.29 4.26 4.00 4.29 4.02 4.13 
hsa-miR-452-
star_st 
3.98 4.00 4.14 4.01 4.55 4.06 4.12 
hsa-miR-889_st 3.54 3.90 4.07 4.11 4.63 4.49 4.12 
hsa-miR-1204_st 3.89 3.84 4.14 4.31 4.15 4.40 4.12 
hsa-miR-620_st 3.90 4.07 4.25 4.03 4.28 4.19 4.12 
hsa-miR-371-3p_st 3.94 3.95 4.07 4.26 4.81 3.68 4.12 
hsa-miR-455-5p_st 4.79 3.54 4.30 3.97 4.10 4.01 4.12 
hsa-miR-567_st 4.17 4.21 4.01 4.54 3.92 3.85 4.12 
hsa-miR-19a_st 4.17 4.06 4.18 4.01 4.12 4.16 4.12 
hsa-miR-122-
star_st 
4.14 4.05 4.11 4.10 4.16 4.14 4.12 
hsa-miR-154-
star_st 
4.13 3.95 4.07 4.03 3.78 4.72 4.11 
hsa-miR-183-
star_st 
4.05 4.00 4.11 4.31 4.12 4.09 4.11 
hsa-miR-622_st 3.54 3.72 4.02 4.36 4.72 4.30 4.11 
hsa-miR-1291_st 3.90 3.64 4.35 4.20 4.94 3.63 4.11 
hsa-miR-656_st 4.10 3.98 4.01 4.17 4.33 4.07 4.11 
hsa-miR-1257_st 4.60 4.28 3.81 3.96 4.03 3.99 4.11 
hsa-miR-92a-2-
star_st 
4.03 3.92 4.09 3.99 4.14 4.46 4.11 
hsa-miR-558_st 3.64 4.47 3.94 4.03 4.32 4.23 4.11 
hsa-miR-7-1-star_st 4.25 3.97 4.15 3.97 4.13 4.15 4.10 
hsa-miR-363_st 3.88 4.07 3.78 3.87 4.62 4.40 4.10 
hsa-miR-452_st 4.36 4.08 4.29 4.10 3.87 3.89 4.10 
hsa-miR-1252_st 4.38 4.15 4.22 4.00 3.87 3.97 4.10 
hsa-miR-598_st 4.35 4.12 4.01 4.27 3.72 4.12 4.10 
hsa-miR-561_st 4.01 4.40 4.27 4.16 3.65 4.09 4.10 
hsa-miR-1226_st 3.81 4.31 3.91 4.20 4.36 3.97 4.09 
hsa-miR-519d_st 4.08 4.57 4.09 4.21 3.91 3.70 4.09 
! [II!
hsa-miR-760_st 3.91 4.21 3.90 4.28 4.06 4.18 4.09 
hsa-miR-650_st 3.91 3.63 4.50 4.03 4.43 4.02 4.09 
hsa-miR-9-star_st 3.87 4.26 4.06 4.06 4.12 4.14 4.09 
hsa-miR-200c_st 4.23 4.17 3.89 4.15 4.05 4.01 4.08 
hsa-miR-34b-
star_st 
4.15 3.91 4.01 4.09 3.91 4.43 4.08 
hsa-miR-205_st 4.28 3.86 3.94 4.08 4.65 3.67 4.08 
hsa-miR-552_st 4.35 3.90 4.15 4.20 4.15 3.71 4.08 
hsa-miR-369-5p_st 3.95 4.10 4.20 4.47 3.46 4.29 4.08 
hsa-miR-624-
star_st 
4.04 3.97 3.98 4.05 4.51 3.90 4.08 
hsa-miR-379-
star_st 
3.90 3.84 4.24 4.06 4.28 4.13 4.07 
hsa-miR-1298_st 4.36 3.79 4.03 4.27 3.90 4.09 4.07 
hsa-miR-192_st 4.05 4.15 3.82 3.98 4.43 3.99 4.07 
hsa-miR-1263_st 3.72 4.09 4.46 3.89 4.13 4.12 4.07 
hsa-miR-575_st 3.74 4.19 4.19 3.83 3.97 4.46 4.07 
hsa-miR-18b_st 4.36 3.89 3.57 4.35 4.02 4.21 4.07 
hsa-miR-767-3p_st 4.10 4.18 3.98 4.01 3.93 4.18 4.06 
hsa-miR-593_st 3.89 4.21 3.86 4.19 3.99 4.23 4.06 
hsa-miR-410_st 3.72 3.82 4.31 4.30 3.95 4.27 4.06 
hsa-miR-33a-
star_st 
4.66 4.10 3.94 4.26 3.52 3.89 4.06 
hsa-miR-618_st 3.91 3.92 4.21 4.32 4.15 3.85 4.06 
hsa-miR-362-3p_st 3.78 3.82 3.96 4.21 4.28 4.30 4.06 
hsa-let-7c-star_st 4.16 4.10 3.88 3.93 4.28 3.98 4.05 
hsa-miR-550_st 4.35 3.65 3.97 3.66 4.21 4.46 4.05 
hsa-miR-325_st 3.91 3.94 4.01 4.36 3.92 4.15 4.05 
hsa-miR-99a-
star_st 
3.87 3.89 3.99 4.66 3.80 4.08 4.05 
hsa-miR-32-star_st 4.30 4.18 3.84 4.09 3.63 4.21 4.04 
hsa-miR-520d-
3p_st 
3.80 4.74 3.88 3.88 3.85 4.10 4.04 
hsa-miR-218-1-
star_st 
4.53 3.87 4.07 4.03 3.76 4.00 4.04 
hsa-miR-1255b_st 4.19 3.89 3.45 3.93 4.66 4.12 4.04 
hsa-miR-591_st 3.96 3.97 4.19 3.90 4.23 3.97 4.04 
hsa-miR-941_st 4.20 4.48 4.12 4.05 4.05 3.32 4.03 
hsa-miR-377_st 3.82 3.92 4.28 4.05 4.09 4.06 4.03 
hsa-miR-219-2-
3p_st 
4.07 4.12 4.15 3.86 4.06 3.92 4.03 
hsa-miR-1_st 4.10 4.47 3.94 3.95 3.65 4.08 4.03 
hsa-miR-203_st 3.89 4.08 3.85 4.15 4.32 3.91 4.03 
hsa-miR-211_st 4.10 3.82 4.49 3.84 4.12 3.81 4.03 
hsa-miR-657_st 3.88 4.31 4.08 4.14 3.83 3.93 4.03 
hsa-miR-1284_st 3.99 3.78 3.75 4.24 4.18 4.22 4.03 
hsa-miR-548b-
3p_st 
4.13 4.06 4.08 4.01 4.06 3.84 4.03 
hsa-miR-101_st 3.91 4.38 4.09 3.68 4.14 3.94 4.02 
hsa-miR-330-5p_st 3.81 4.70 4.21 3.86 3.46 4.08 4.02 
hsa-miR-491-3p_st 4.11 3.82 4.08 3.83 4.18 4.08 4.02 
hsa-miR-520h_st 3.95 4.18 3.80 4.21 3.92 4.07 4.02 
hsa-miR-215_st 3.96 3.77 3.82 3.83 4.44 4.29 4.02 
hsa-miR-631_st 3.92 3.76 4.38 3.63 4.45 3.96 4.02 
hsa-miR-577_st 3.73 3.93 4.36 4.03 4.04 3.99 4.02 
hsa-miR-194-
star_st 
3.85 3.72 4.24 4.06 4.36 3.84 4.01 
hsa-miR-548d-
3p_st 
3.65 3.73 3.92 4.36 4.32 4.07 4.01 
! [IL!
hsa-miR-1245_st 3.71 3.93 4.12 4.35 3.91 4.03 4.01 
hsa-miR-944_st 4.45 4.13 3.85 4.19 3.82 3.61 4.01 
hsa-miR-579_st 4.30 3.67 3.96 3.89 4.28 3.93 4.01 
hsa-miR-542-3p_st 4.16 3.68 4.27 3.93 3.88 4.11 4.01 
hsa-miR-497-
star_st 
4.02 3.68 3.84 3.94 4.50 4.05 4.01 
hsa-miR-628-5p_st 4.15 3.90 4.06 4.11 3.67 4.11 4.00 
hsa-miR-298_st 3.85 4.47 4.32 3.55 3.89 3.91 4.00 
hsa-miR-182_st 4.21 3.99 3.76 3.96 3.96 4.12 4.00 
hsa-miR-300_st 3.89 4.27 4.12 3.81 4.00 3.91 4.00 
hsa-miR-200c-
star_st 
3.58 4.50 4.00 4.34 3.95 3.62 4.00 
hsa-miR-616-
star_st 
3.53 4.08 4.06 4.07 4.55 3.69 4.00 
hsa-miR-1226-
star_st 
4.04 4.14 4.80 3.01 3.83 4.16 4.00 
hsa-miR-621_st 3.95 3.88 3.83 3.93 4.17 4.23 4.00 
hsa-miR-135b-
star_st 
4.05 4.29 3.80 4.03 3.87 3.94 4.00 
hsa-miR-553_st 4.01 3.82 4.03 3.68 4.25 4.14 3.99 
hsa-miR-1827_st 3.73 3.73 4.14 3.88 4.45 4.00 3.99 
hsa-miR-155-
star_st 
3.88 3.98 3.97 4.18 4.13 3.78 3.99 
hsa-miR-380-
star_st 
4.12 3.89 4.11 4.04 3.75 4.00 3.99 
hsa-miR-643_st 4.21 4.10 4.35 3.98 3.56 3.72 3.99 
hsa-miR-1324_st 4.29 3.98 3.74 4.06 3.80 4.05 3.99 
hsa-miR-508-5p_st 3.77 3.90 4.26 4.05 4.09 3.84 3.99 
hsa-miR-142-3p_st 3.89 4.04 3.82 4.21 4.06 3.89 3.99 
hsa-miR-432-
star_st 
3.85 4.03 3.63 3.90 4.23 4.26 3.98 
hsa-miR-1305_st 3.89 4.22 3.63 4.16 4.07 3.94 3.98 
hsa-miR-124_st 3.99 4.31 3.93 3.81 3.98 3.88 3.98 
hsa-miR-548j_st 3.84 3.94 4.24 3.95 3.93 4.00 3.98 
hsa-miR-607_st 3.94 4.36 3.66 4.03 4.02 3.89 3.98 
hsa-miR-548i_st 4.23 4.13 3.85 3.72 4.10 3.85 3.98 
hsa-miR-630_st 3.99 3.99 4.06 3.86 4.07 3.91 3.98 
hsa-miR-340_st 3.92 4.10 3.84 4.18 3.83 4.01 3.98 
hsa-miR-206_st 4.10 4.08 3.96 4.03 3.90 3.81 3.98 
hsa-miR-600_st 3.97 3.84 4.09 3.86 4.36 3.76 3.98 
hsa-miR-891b_st 4.05 4.04 3.97 3.92 3.94 3.95 3.98 
hsa-miR-186-
star_st 
4.01 4.09 3.92 4.03 3.90 3.91 3.98 
hsa-let-7i-star_st 3.59 4.49 3.97 3.92 3.68 4.22 3.98 
hsa-miR-15a-
star_st 
3.50 3.89 3.94 4.17 4.10 4.25 3.98 
hsa-miR-135a_st 3.92 3.86 4.24 3.92 3.79 4.11 3.98 
hsa-miR-891a_st 3.72 3.69 4.05 4.59 4.00 3.80 3.97 
hsa-miR-548a-
5p_st 
3.84 4.03 3.81 4.29 3.87 4.00 3.97 
hsa-miR-1253_st 4.34 3.88 3.72 4.10 3.84 3.96 3.97 
hsa-miR-518f-
star_st 
4.21 3.96 4.06 3.75 3.90 3.95 3.97 
hsa-miR-412_st 3.76 3.78 4.35 3.99 3.86 4.10 3.97 
hsa-miR-651_st 3.82 4.20 3.76 4.06 3.88 4.10 3.97 
hsa-miR-569_st 3.89 4.08 3.83 4.13 3.80 4.10 3.97 
hsa-miR-589_st 4.05 4.36 3.69 3.92 3.99 3.81 3.97 
hsa-miR-30b-
star_st 
4.04 3.73 3.89 3.86 4.17 4.09 3.96 
hsa-miR-26a-2- 3.71 4.56 3.72 4.03 3.86 3.90 3.96 
! [I[!
star_st 
hsa-miR-548g_st 3.93 3.73 4.02 4.06 4.01 4.02 3.96 
hsa-miR-590-3p_st 3.97 3.92 3.90 3.92 4.11 3.94 3.96 
hsa-miR-186_st 4.06 4.05 3.94 3.87 3.95 3.87 3.96 
hsa-miR-302b-
star_st 
3.78 4.13 3.93 4.11 3.74 4.06 3.96 
hsa-miR-302f_st 3.98 4.02 3.68 4.46 3.68 3.92 3.96 
hsa-miR-16-2-
star_st 
3.87 3.81 4.34 3.83 3.93 3.95 3.96 
hsa-miR-551a_st 3.74 3.84 3.74 4.14 4.38 3.88 3.96 
hsa-miR-545-
star_st 
3.85 4.16 4.38 3.80 3.62 3.92 3.95 
hsa-miR-549_st 4.03 4.00 4.15 4.06 3.61 3.85 3.95 
hsa-miR-1182_st 4.05 4.08 4.42 3.69 3.59 3.88 3.95 
hsa-miR-548n_st 3.98 4.27 4.02 3.82 3.80 3.81 3.95 
hsa-miR-372_st 4.15 3.89 4.00 3.98 3.78 3.90 3.95 
hsa-miR-1299_st 3.96 4.00 3.83 3.82 3.95 4.13 3.95 
hsa-miR-202_st 3.72 3.76 4.04 4.30 3.78 4.10 3.95 
hsa-miR-376a-
star_st 
4.07 4.01 3.99 4.05 3.67 3.90 3.95 
hsa-miR-188-3p_st 3.99 3.95 4.23 4.17 3.58 3.77 3.95 
hsa-miR-519b-
3p_st 
3.94 3.78 4.00 4.27 3.80 3.90 3.95 
hsa-miR-376b_st 3.58 3.99 3.75 3.98 4.15 4.23 3.95 
hsa-miR-520a-
3p_st 
3.90 4.13 4.07 4.00 3.84 3.74 3.95 
hsa-miR-541_st 3.67 3.73 4.14 4.35 4.06 3.74 3.95 
hsa-miR-936_st 3.69 4.01 4.18 3.95 4.25 3.59 3.95 
hsa-miR-1201_st 3.91 3.90 3.94 3.72 4.10 4.10 3.94 
hsa-miR-429_st 4.21 3.93 3.97 3.96 3.85 3.75 3.94 
hsa-miR-524-5p_st 3.98 3.94 3.91 3.72 3.98 4.13 3.94 
hsa-miR-515-5p_st 3.90 4.34 3.61 3.76 4.45 3.60 3.94 
hsa-miR-640_st 3.70 3.64 4.14 4.17 3.78 4.23 3.94 
hsa-miR-521_st 3.89 3.90 4.26 3.77 3.91 3.92 3.94 
hsa-miR-1264_st 4.27 4.12 4.18 3.82 3.71 3.55 3.94 
hsa-miR-509-3-
5p_st 
4.18 4.07 4.35 3.58 3.88 3.59 3.94 
hsa-miR-617_st 3.89 3.88 4.06 3.80 3.93 4.09 3.94 
hsa-miR-597_st 4.08 4.03 3.93 3.78 4.03 3.80 3.94 
hsa-miR-518e_st 4.20 3.83 3.89 3.97 3.90 3.85 3.94 
hsa-miR-301a_st 4.06 3.94 3.67 4.26 3.90 3.80 3.94 
hsa-miR-20b-
star_st 
3.91 4.04 3.82 3.89 3.61 4.36 3.94 
hsa-miR-200b_st 3.86 4.09 3.72 3.95 4.25 3.75 3.93 
hsa-miR-182-
star_st 
4.09 4.03 3.77 4.18 3.86 3.66 3.93 
hsa-miR-548l_st 4.14 3.91 3.91 3.89 4.06 3.68 3.93 
hsa-miR-548c-
5p_st 
3.99 3.93 3.99 4.12 3.92 3.65 3.93 
hsa-miR-568_st 4.08 3.91 4.04 4.05 3.65 3.85 3.93 
hsa-miR-374a_st 3.92 3.85 4.06 3.75 3.66 4.34 3.93 
hsa-miR-555_st 3.84 3.87 3.72 4.15 3.90 4.09 3.93 
hsa-miR-653_st 4.24 3.82 3.72 3.78 4.09 3.94 3.93 
hsa-miR-453_st 3.88 4.29 3.93 3.84 3.56 4.07 3.93 
hsa-miR-144_st 3.71 3.87 4.09 3.97 4.00 3.94 3.93 
hsa-miR-384_st 3.78 3.89 3.92 4.11 3.98 3.88 3.93 
hsa-miR-586_st 3.99 3.83 3.77 4.20 3.88 3.89 3.93 




3.79 3.48 4.24 4.63 3.71 3.69 3.92 
hsa-miR-578_st 3.73 4.44 3.85 3.73 3.79 4.01 3.92 
hsa-miR-624_st 3.66 4.06 4.09 3.93 4.05 3.74 3.92 
hsa-miR-380_st 3.86 4.12 3.85 3.88 3.84 3.97 3.92 
hsa-miR-1270_st 3.79 3.88 4.03 3.96 3.99 3.85 3.92 
hsa-miR-1259_st 3.80 3.83 4.04 4.08 3.83 3.93 3.92 
hsa-miR-527_st 4.27 3.85 3.94 3.89 3.86 3.70 3.92 
hsa-miR-1278_st 3.69 3.88 3.81 3.99 3.98 4.14 3.92 
hsa-miR-1294_st 4.43 3.94 3.68 3.76 4.03 3.64 3.91 
hsa-miR-488-
star_st 
4.10 4.15 3.72 3.71 3.89 3.92 3.91 
hsa-miR-708-
star_st 
3.88 4.04 3.85 3.70 3.96 4.04 3.91 
hsa-miR-450b-
5p_st 
3.97 4.12 3.88 3.90 3.75 3.84 3.91 
hsa-miR-369-3p_st 3.91 3.80 4.06 4.08 3.85 3.76 3.91 
hsa-miR-92a-1-
star_st 
3.65 4.26 3.92 3.78 4.04 3.82 3.91 
hsa-miR-875-5p_st 4.00 3.73 3.85 4.07 3.87 3.94 3.91 
hsa-miR-183_st 3.92 4.11 4.03 4.06 3.79 3.56 3.91 
hsa-miR-1286_st 3.77 4.31 3.94 3.85 4.11 3.48 3.91 
hsa-miR-220c_st 3.82 3.94 3.91 4.27 3.64 3.87 3.91 
hsa-miR-1277_st 3.94 3.78 4.02 3.96 3.77 3.98 3.91 
hsa-miR-23a-
star_st 
3.99 3.79 3.35 4.16 4.08 4.08 3.91 
hsa-miR-513a-
3p_st 
3.96 3.88 4.02 3.82 3.89 3.87 3.91 
hsa-miR-145-
star_st 
3.97 4.08 3.91 3.65 4.02 3.82 3.91 
hsa-miR-142-5p_st 3.80 4.10 3.80 3.89 3.85 3.99 3.91 
hsa-miR-1250_st 4.00 3.94 3.73 3.80 3.90 4.06 3.91 
hsa-miR-934_st 3.97 4.00 3.90 3.80 4.02 3.73 3.90 
hsa-miR-16-1-
star_st 
4.65 3.79 3.56 3.64 3.79 3.98 3.90 
hsa-miR-302d-
star_st 
4.18 3.59 3.73 4.00 4.15 3.78 3.90 
hsa-miR-517a_st 4.10 3.90 3.89 3.83 3.77 3.92 3.90 
hsa-miR-518d-
5p_st 
3.89 4.09 4.12 3.64 3.92 3.75 3.90 
hsa-miR-519e_st 3.81 4.01 4.13 3.78 3.81 3.87 3.90 
hsa-miR-1266_st 3.83 3.92 3.99 4.32 3.82 3.52 3.90 
hsa-miR-374b-
star_st 
4.03 4.02 3.68 3.72 3.74 4.20 3.90 
hsa-miR-548h_st 3.78 4.03 3.79 3.87 4.33 3.59 3.90 
hsa-miR-192-
star_st 
3.64 4.15 3.60 3.77 4.17 4.07 3.90 
hsa-miR-520c-
5p_st 
3.90 4.24 4.06 4.04 3.59 3.56 3.90 
hsa-miR-509-5p_st 3.79 3.88 3.98 3.77 3.89 4.07 3.90 
hsa-miR-518a-
5p_st 
3.84 3.99 3.97 3.79 4.05 3.72 3.90 
hsa-miR-184_st 3.95 3.80 3.88 3.83 3.82 4.10 3.90 
hsa-miR-587_st 4.09 4.08 3.91 3.86 3.80 3.62 3.90 
hsa-miR-141_st 3.74 3.98 3.87 3.87 3.98 3.93 3.89 
hsa-miR-302a-
star_st 
3.78 3.92 4.10 4.03 3.75 3.78 3.89 
hsa-miR-7_st 3.82 3.77 3.84 4.00 4.07 3.84 3.89 
hsa-miR-1292_st 3.53 4.85 3.08 2.99 3.85 5.06 3.89 
hsa-miR-1251_st 3.82 3.77 3.91 4.21 3.68 3.95 3.89 




4.03 3.85 3.68 3.99 4.02 3.75 3.89 
hsa-miR-18a-
star_st 
3.22 4.58 3.90 3.90 3.72 4.01 3.89 
hsa-miR-590-5p_st 3.72 3.92 4.24 3.82 3.95 3.67 3.89 
hsa-miR-431-
star_st 
4.14 3.62 4.10 4.30 3.61 3.54 3.88 
hsa-miR-570_st 3.81 4.09 3.76 4.05 3.78 3.83 3.88 
hsa-miR-585_st 3.91 3.88 3.79 3.84 4.11 3.77 3.88 
hsa-miR-499-3p_st 3.97 3.79 3.82 4.10 3.72 3.89 3.88 
hsa-miR-105-
star_st 
4.42 3.70 3.79 3.50 3.85 4.01 3.88 
hsa-miR-218-2-
star_st 
4.06 4.24 3.81 3.57 3.72 3.88 3.88 
hsa-miR-616_st 3.69 3.90 3.99 3.83 3.93 3.93 3.88 
hsa-miR-580_st 3.78 3.99 3.97 3.88 3.77 3.87 3.88 
hsa-miR-502-5p_st 3.66 3.74 4.14 3.82 3.75 4.15 3.88 
hsa-miR-514_st 3.86 4.17 3.68 4.04 3.98 3.53 3.88 
hsa-miR-218_st 4.05 3.73 3.77 3.66 4.07 3.98 3.88 
hsa-miR-301b_st 3.90 3.91 4.18 3.49 4.09 3.68 3.87 
hsa-miR-516a-
5p_st 
3.97 4.37 3.51 3.67 3.92 3.81 3.87 
hsa-miR-95_st 3.89 3.64 3.88 3.91 4.27 3.64 3.87 
hsa-miR-331-5p_st 3.76 3.93 3.76 3.86 3.95 3.97 3.87 
hsa-miR-1302_st 3.67 4.10 3.58 4.02 3.74 4.12 3.87 
hsa-miR-144-
star_st 
3.83 3.69 3.99 3.83 3.94 3.95 3.87 
hsa-miR-613_st 3.75 3.95 3.95 3.80 4.00 3.77 3.87 
hsa-miR-1276_st 3.81 3.87 3.92 3.80 3.90 3.93 3.87 
hsa-miR-876-5p_st 3.95 3.87 4.15 3.97 3.74 3.53 3.87 
hsa-miR-19b-1-
star_st 
3.90 3.74 3.93 3.83 3.85 3.96 3.87 
hsa-miR-20a-
star_st 
3.88 3.73 3.82 3.94 3.98 3.85 3.87 
hsa-miR-302c-
star_st 
3.62 4.02 3.93 3.83 3.98 3.82 3.87 
hsa-miR-105_st 3.89 4.00 3.97 3.93 3.60 3.81 3.87 
hsa-miR-1185_st 3.81 3.97 3.80 4.04 3.78 3.81 3.87 
hsa-miR-1261_st 3.70 3.92 3.70 3.92 3.84 4.12 3.87 
hsa-miR-1265_st 4.23 3.60 3.84 3.75 3.86 3.92 3.87 
hsa-miR-609_st 3.63 3.72 3.92 4.06 4.24 3.62 3.87 
hsa-miR-576-5p_st 3.84 4.08 3.92 3.76 3.80 3.79 3.86 
hsa-miR-554_st 3.99 3.86 3.69 3.90 3.90 3.86 3.86 
hsa-miR-522_st 3.78 3.84 3.84 3.94 3.96 3.82 3.86 
hsa-miR-29a-
star_st 
3.87 3.85 3.96 3.93 3.85 3.72 3.86 
hsa-miR-367-
star_st 
3.81 4.00 3.89 4.00 3.65 3.83 3.86 
hsa-miR-126-
star_st 
3.79 4.08 3.76 3.98 3.90 3.66 3.86 
hsa-miR-1248_st 3.78 3.95 4.19 3.70 3.78 3.77 3.86 
hsa-miR-1297_st 3.78 3.84 3.93 3.78 3.76 4.09 3.86 
hsa-miR-1279_st 3.97 3.51 4.09 4.08 3.79 3.73 3.86 
hsa-miR-582-5p_st 4.10 3.79 3.93 3.87 3.76 3.72 3.86 
hsa-miR-770-5p_st 3.63 3.36 3.90 4.43 3.94 3.91 3.86 
hsa-miR-153_st 3.86 4.04 3.54 3.71 3.84 4.16 3.86 
hsa-miR-383_st 3.83 3.79 4.09 3.93 3.90 3.61 3.86 
hsa-miR-648_st 3.90 3.90 3.58 3.72 4.10 3.95 3.86 
hsa-miR-1206_st 3.82 3.91 3.77 3.75 4.07 3.83 3.86 
hsa-miR-518c- 3.61 3.73 4.28 3.66 3.99 3.86 3.85 
! [I`!
star_st 
hsa-miR-1283_st 3.87 3.94 4.04 3.97 3.75 3.56 3.85 
hsa-miR-556-5p_st 3.71 3.70 3.94 3.99 4.05 3.74 3.85 
hsa-miR-135b_st 3.91 3.85 3.77 3.66 3.90 4.02 3.85 
hsa-miR-1197_st 4.35 3.58 3.87 3.92 3.82 3.57 3.85 
hsa-miR-610_st 3.97 3.91 3.74 3.94 3.95 3.60 3.85 
hsa-let-7a-star_st 3.93 3.87 3.86 3.91 3.65 3.90 3.85 
hsa-miR-512-5p_st 3.79 3.98 3.74 3.60 4.06 3.93 3.85 
hsa-miR-525-3p_st 3.69 3.87 4.06 3.94 3.60 3.96 3.85 
hsa-miR-876-3p_st 3.63 3.91 3.77 4.03 3.87 3.88 3.85 
hsa-miR-513c_st 3.78 3.84 4.16 3.75 3.94 3.61 3.85 
hsa-miR-190b_st 3.95 3.68 3.94 3.66 3.97 3.88 3.85 
hsa-miR-200a-
star_st 
3.60 4.55 3.82 3.87 3.59 3.66 3.85 
hsa-miR-655_st 3.87 3.87 3.78 3.83 4.01 3.72 3.85 
hsa-miR-190_st 4.10 3.82 3.67 3.90 3.86 3.74 3.85 
hsa-miR-875-3p_st 3.77 3.62 3.98 4.08 3.80 3.82 3.85 
hsa-miR-122_st 3.89 3.71 3.82 3.88 3.94 3.81 3.84 
hsa-miR-1306_st 3.76 4.16 3.70 3.96 3.53 3.95 3.84 
hsa-miR-146a-
star_st 
3.82 3.98 3.76 3.70 3.73 4.07 3.84 
hsa-miR-486-3p_st 3.69 3.62 4.10 3.72 4.14 3.78 3.84 
hsa-miR-922_st 3.94 4.02 3.91 3.77 3.61 3.81 3.84 
hsa-miR-1321_st 3.68 4.20 3.60 3.80 3.92 3.84 3.84 
hsa-miR-649_st 3.84 3.81 3.97 3.79 3.75 3.86 3.84 
hsa-miR-511_st 3.93 3.69 3.88 3.87 3.98 3.67 3.84 
hsa-miR-26b-
star_st 
3.63 3.99 3.90 4.11 3.66 3.73 3.84 
hsa-miR-220b_st 3.53 3.75 4.01 4.27 3.57 3.88 3.84 
hsa-miR-518a-
3p_st 
3.98 4.02 3.79 3.79 3.72 3.71 3.84 
hsa-let-7g-star_st 3.92 3.81 3.97 3.59 3.59 4.13 3.83 
hsa-miR-297_st 3.85 3.88 3.94 3.77 3.70 3.86 3.83 
hsa-miR-517b_st 3.67 4.04 3.73 3.80 3.94 3.80 3.83 
hsa-miR-488_st 3.99 3.57 3.64 3.82 4.21 3.76 3.83 
hsa-miR-647_st 4.10 3.84 3.85 3.76 3.47 3.98 3.83 
hsa-miR-520e_st 4.03 3.72 3.82 4.05 3.65 3.72 3.83 
hsa-miR-496_st 4.03 3.78 3.79 3.80 3.65 3.93 3.83 
hsa-miR-138-2-
star_st 
3.81 4.03 3.54 3.86 4.04 3.71 3.83 
hsa-miR-373_st 3.72 3.87 3.74 3.90 3.84 3.91 3.83 
hsa-miR-302a_st 4.26 3.55 3.94 3.84 3.92 3.46 3.83 
hsa-miR-139-5p_st 3.75 4.09 3.92 3.88 3.88 3.44 3.83 
hsa-miR-632_st 4.12 3.80 3.86 3.58 3.84 3.76 3.83 
hsa-miR-767-5p_st 3.79 3.79 4.06 3.89 3.72 3.71 3.83 
hsa-miR-1207-
3p_st 
3.74 3.74 3.55 4.01 4.04 3.89 3.83 
hsa-miR-556-3p_st 3.90 3.89 3.67 3.78 3.75 3.97 3.83 
hsa-miR-32_st 4.07 3.79 3.68 3.74 3.92 3.75 3.82 
hsa-miR-1282_st 3.65 4.07 3.77 3.88 3.81 3.76 3.82 
hsa-miR-451_st 3.92 3.92 3.68 4.00 3.88 3.54 3.82 
hsa-miR-545_st 3.45 4.10 3.86 3.90 3.87 3.76 3.82 
hsa-miR-139-3p_st 3.47 3.89 3.72 3.83 4.33 3.68 3.82 
hsa-miR-96_st 4.01 3.79 3.88 3.77 3.71 3.75 3.82 
hsa-miR-520c-
3p_st 
4.05 3.86 3.94 3.63 3.61 3.83 3.82 
hsa-miR-136- 3.80 3.84 3.72 4.02 3.91 3.61 3.82 
! [Ia!
star_st 
hsa-miR-544_st 3.71 3.86 3.75 3.80 3.90 3.88 3.82 
hsa-miR-150_st 3.76 3.78 3.82 3.93 3.80 3.81 3.82 
hsa-miR-619_st 3.72 3.68 3.97 3.97 3.43 4.12 3.82 
hsa-miR-601_st 3.58 4.05 3.83 3.83 3.64 3.97 3.82 
hsa-miR-510_st 3.73 3.76 3.52 3.85 3.84 4.18 3.81 
hsa-miR-548b-
5p_st 
3.90 3.85 3.69 3.98 3.64 3.81 3.81 
hsa-miR-518c_st 3.85 3.89 3.85 3.52 4.02 3.75 3.81 
hsa-miR-106a-
star_st 
3.99 3.75 4.13 3.79 3.70 3.51 3.81 
hsa-miR-302b_st 3.92 3.68 3.88 3.87 3.73 3.79 3.81 
hsa-miR-548k_st 3.84 3.89 3.97 3.80 3.67 3.69 3.81 
hsa-miR-196a_st 3.61 4.18 3.77 3.72 3.97 3.60 3.81 
hsa-miR-548d-
5p_st 
3.93 3.84 3.68 3.71 3.83 3.86 3.81 
hsa-miR-1256_st 4.06 3.66 3.55 3.71 3.83 4.03 3.81 
hsa-miR-196b_st 4.18 3.73 3.65 3.76 3.80 3.72 3.81 
hsa-miR-520d-
5p_st 
3.85 3.48 3.96 3.74 4.14 3.65 3.80 
hsa-miR-646_st 3.45 4.06 3.68 4.10 3.64 3.89 3.80 
hsa-miR-450a_st 4.21 3.92 3.54 3.66 3.61 3.87 3.80 
hsa-miR-1243_st 3.65 3.85 3.84 3.79 3.77 3.90 3.80 
hsa-miR-141-
star_st 
3.85 3.64 3.75 3.62 3.90 4.04 3.80 
hsa-miR-148b-
star_st 
3.80 3.88 3.84 3.98 3.69 3.61 3.80 
hsa-miR-148a-
star_st 
3.90 3.50 4.08 3.79 3.83 3.69 3.80 
hsa-miR-518d-
3p_st 
3.97 3.97 3.34 3.97 4.03 3.51 3.80 
hsa-miR-890_st 3.74 3.95 3.94 3.47 3.91 3.78 3.80 
hsa-miR-588_st 3.76 3.60 3.95 3.51 4.17 3.78 3.80 
hsa-miR-507_st 3.65 3.51 3.71 4.10 4.05 3.76 3.80 
hsa-miR-566_st 3.94 3.47 3.69 3.86 3.88 3.94 3.79 
hsa-miR-200b-
star_st 
4.01 3.57 3.93 3.91 3.71 3.62 3.79 
hsa-miR-448_st 3.80 3.76 3.80 3.90 3.78 3.72 3.79 
hsa-miR-450b-
3p_st 
4.01 3.70 3.60 3.78 3.85 3.81 3.79 
hsa-miR-662_st 3.95 3.50 3.48 4.03 3.84 3.94 3.79 
hsa-miR-136_st 3.68 3.62 3.83 3.72 3.86 4.04 3.79 
hsa-miR-30d-
star_st 
4.08 3.72 3.83 3.77 3.65 3.71 3.79 
hsa-miR-515-3p_st 3.51 3.80 3.91 3.93 3.84 3.73 3.79 
hsa-miR-562_st 3.67 4.13 3.71 3.62 4.04 3.56 3.79 
hsa-miR-509-3p_st 3.64 3.43 4.19 4.02 3.79 3.66 3.79 
hsa-miR-216a_st 4.01 3.63 3.62 3.78 3.80 3.87 3.79 
hsa-miR-526b_st 3.82 3.66 3.89 3.83 3.78 3.73 3.79 
hsa-miR-523_st 3.68 3.96 3.97 3.71 3.70 3.69 3.78 
hsa-miR-519e-
star_st 
4.10 4.00 3.35 3.68 3.73 3.83 3.78 
hsa-miR-551b_st 3.79 3.99 3.71 3.66 3.65 3.90 3.78 
hsa-miR-1179_st 3.67 3.96 3.59 3.84 3.82 3.81 3.78 
hsa-miR-130a-
star_st 
3.78 3.96 3.70 3.76 3.85 3.64 3.78 
hsa-miR-924_st 3.97 3.70 3.76 3.92 3.69 3.63 3.78 
hsa-miR-100-
star_st 
3.84 3.88 3.79 3.62 3.75 3.81 3.78 




3.85 3.70 3.73 3.96 3.85 3.56 3.78 
hsa-miR-517c_st 4.01 3.58 3.74 3.78 3.73 3.81 3.78 
hsa-miR-1289_st 3.76 3.60 3.73 3.89 3.90 3.77 3.77 
hsa-miR-519a_st 3.63 3.68 3.79 4.16 3.65 3.72 3.77 
hsa-miR-519c-
3p_st 
3.72 3.98 3.56 3.66 3.80 3.91 3.77 
hsa-miR-147_st 4.04 3.93 3.70 3.88 3.47 3.61 3.77 
hsa-miR-524-3p_st 3.65 3.73 3.68 4.06 3.73 3.79 3.77 
hsa-miR-599_st 3.85 3.62 3.79 3.71 3.66 4.00 3.77 
hsa-miR-1322_st 4.23 3.46 3.65 3.46 4.13 3.70 3.77 
hsa-miR-592_st 3.59 3.94 3.81 3.83 3.74 3.73 3.77 
hsa-miR-302e_st 3.81 3.85 3.63 3.81 3.72 3.82 3.77 
hsa-miR-603_st 3.70 3.84 4.02 3.61 3.78 3.68 3.77 
hsa-miR-1178_st 3.82 3.66 3.46 4.03 3.79 3.87 3.77 
hsa-miR-573_st 4.05 3.50 4.11 3.30 3.75 3.90 3.77 
hsa-miR-644_st 3.58 3.89 4.02 3.78 3.59 3.73 3.77 
hsa-miR-363-
star_st 
3.53 3.61 4.09 3.91 3.69 3.76 3.76 
hsa-miR-15b-
star_st 
3.92 3.78 3.86 3.71 3.78 3.53 3.76 
hsa-miR-19a-
star_st 
3.45 3.75 3.84 3.93 3.84 3.76 3.76 
hsa-miR-1200_st 3.92 3.53 4.22 3.70 3.45 3.76 3.76 
hsa-miR-548a-
3p_st 
3.67 3.76 3.87 3.80 3.75 3.71 3.76 
hsa-miR-526b-
star_st 
4.06 3.64 3.66 3.87 3.68 3.66 3.76 
hsa-miR-937_st 3.49 3.65 3.70 3.60 4.14 3.97 3.76 
hsa-miR-200a_st 3.66 3.57 3.93 3.71 3.66 4.02 3.76 
hsa-miR-10b-
star_st 
3.72 3.84 3.83 4.01 3.54 3.62 3.76 
hsa-miR-526a_st 3.94 3.88 3.81 3.61 3.75 3.56 3.76 
hsa-miR-548o_st 3.65 3.58 4.32 3.62 3.59 3.78 3.76 
hsa-miR-217_st 4.31 3.31 3.58 3.76 3.94 3.63 3.76 
hsa-miR-642_st 3.55 3.94 3.71 3.74 3.90 3.68 3.76 
hsa-miR-367_st 3.58 3.86 3.72 3.69 3.96 3.72 3.75 
hsa-miR-101-
star_st 
3.57 3.44 4.15 3.78 3.75 3.83 3.75 
hsa-miR-873_st 3.71 3.69 3.81 3.75 3.68 3.83 3.75 
hsa-miR-302c_st 4.04 3.60 3.73 3.46 3.67 3.96 3.74 
hsa-miR-219-5p_st 3.87 3.68 3.79 3.83 3.60 3.65 3.74 
hsa-miR-604_st 4.04 3.78 3.37 3.68 3.99 3.53 3.73 
hsa-miR-9_st 3.64 3.84 3.75 3.91 3.48 3.76 3.73 
hsa-miR-96-star_st 3.88 3.58 3.79 3.62 3.65 3.86 3.73 
hsa-miR-520f_st 3.95 3.94 3.75 3.61 3.70 3.42 3.73 
hsa-miR-888-
star_st 
3.86 3.59 3.77 3.81 3.80 3.53 3.73 
hsa-miR-581_st 4.13 3.49 3.48 3.74 3.84 3.67 3.73 
hsa-miR-518f_st 3.92 3.66 3.53 3.69 3.80 3.76 3.73 
hsa-miR-645_st 4.00 3.58 3.71 3.54 3.62 3.90 3.72 
hsa-miR-338-3p_st 3.84 3.93 3.75 3.77 3.43 3.61 3.72 
hsa-miR-499-5p_st 3.65 3.68 3.80 3.81 3.81 3.57 3.72 
hsa-miR-147b_st 3.65 3.82 3.79 3.67 3.84 3.55 3.72 
hsa-miR-449a_st 3.74 3.81 3.72 3.74 3.43 3.88 3.72 
hsa-miR-1304_st 3.60 3.90 3.98 3.61 3.76 3.46 3.72 
hsa-miR-512-3p_st 3.49 3.61 3.88 3.97 3.43 3.89 3.71 
hsa-miR-1295_st 3.81 3.54 3.57 3.72 3.85 3.78 3.71 
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hsa-miR-375_st 3.75 3.58 3.58 3.60 3.83 3.89 3.71 
hsa-miR-892b_st 3.83 4.22 3.54 3.60 3.38 3.66 3.71 
hsa-miR-26a-1-
star_st 
3.85 3.63 3.72 3.82 3.51 3.67 3.70 
hsa-miR-202-
star_st 
3.59 3.94 3.55 3.43 3.91 3.77 3.70 
hsa-miR-223-
star_st 
3.60 3.87 3.80 3.72 3.51 3.70 3.70 
hsa-miR-520a-
5p_st 
3.80 4.00 3.46 3.76 3.53 3.63 3.70 
hsa-miR-892a_st 3.89 3.96 3.51 3.84 3.41 3.58 3.70 
hsa-let-7f-2-star_st 3.69 3.75 3.83 3.87 3.38 3.66 3.70 
hsa-miR-302d_st 3.78 3.78 3.72 3.58 3.69 3.61 3.69 
hsa-miR-516b_st 3.84 3.96 3.89 3.67 3.36 3.45 3.69 
hsa-miR-146b-
3p_st 
3.62 4.03 3.51 3.71 3.64 3.62 3.69 
hsa-miR-33a_st 3.71 3.50 4.06 3.77 3.41 3.60 3.68 
hsa-miR-522-
star_st 
3.72 3.72 3.70 3.62 3.74 3.53 3.67 
hsa-miR-33b_st 3.80 3.65 3.58 3.71 3.65 3.62 3.67 
hsa-miR-519c-
5p_st 
3.61 3.77 3.63 3.88 3.40 3.69 3.67 
hsa-miR-1269_st 3.39 4.05 3.49 3.64 3.79 3.62 3.66 
hsa-miR-1205_st 3.84 3.53 3.61 3.83 3.59 3.56 3.66 
hsa-miR-571_st 3.68 3.80 3.64 3.85 3.34 3.64 3.66 
hsa-miR-449b_st 3.66 3.66 3.60 3.73 3.62 3.65 3.65 
hsa-miR-525-5p_st 3.51 4.00 3.60 3.54 3.35 3.88 3.65 
hsa-miR-24-1-
star_st 
3.70 3.39 3.73 3.62 3.48 3.91 3.64 
hsa-miR-519a-
star_st 
4.10 3.75 3.45 3.77 3.30 3.45 3.64 
hsa-miR-1203_st 3.28 3.96 3.63 3.94 3.92 3.09 3.64 
hsa-miR-516b-
star_st 
3.89 3.45 3.75 3.46 3.86 3.39 3.63 
hsa-miR-516a-
3p_st 
3.53 3.60 3.82 3.69 3.58 3.44 3.61 
hsa-miR-187_st 3.52 3.42 3.65 3.44 3.74 3.88 3.61 
hsa-miR-639_st 3.22 3.63 3.99 3.87 3.18 3.72 3.60 
hsa-miR-519b-
5p_st 
3.63 3.88 3.28 3.56 3.55 3.63 3.59 
hsa-miR-942_st 3.68 3.43 3.50 3.39 3.47 4.03 3.58 
hsa-miR-124-
star_st 
3.70 3.81 3.60 3.65 3.38 3.34 3.58 
hsa-miR-663b_st 1.99 4.53 3.57 3.64 4.13 3.61 3.58 
hsa-miR-523-
star_st 
3.43 3.55 3.58 3.69 3.68 3.51 3.57 
hsa-miR-518e-
star_st 
3.64 3.86 3.27 3.45 3.71 3.41 3.55 
hsa-miR-658_st 3.22 4.19 3.64 3.51 3.59 3.02 3.53 
hsa-miR-614_st 3.50 3.13 3.49 3.77 3.03 3.63 3.43 
hsa-miR-323-5p_st 3.02 4.22 3.01 3.04 1.68 2.44 2.90 
hsa-miR-608_st 3.42 2.20 1.05 1.97 2.81 1.86 2.22 
hsa-miR-33b-
star_st 
2.57 2.21 1.91 1.44 2.74 2.08 2.16 
hsa-miR-661_st 4.09 2.54 1.19 1.49 3.45 -0.61 2.02 
hsa-miR-611_st 3.94 -19.25 3.88 3.51 3.43 3.54 -0.16 
hsa-miR-593-
star_st 
3.45 -11.55 2.72 3.59 -11.64 1.72 -1.95 !
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MicroRNAs in lung diseases
Tom Pagdin, Paul Lavender
ABSTRACT
The advent of RNA sequencing technology has
stimulated rapid advances in our understanding of
the transcriptome, including discovery of the vast
RNA complement generated by transcript splice
variation and the expansion of our knowledge of
non-coding RNAs. One non-coding RNA subtype,
microRNAs (miRNAs), are particularly well
studied, primarily because of their important roles
as post-transcriptional gene regulators. The ﬁrst
miRNA was identiﬁed in the early 1990s and there
are now thought to be around 1000 distinct
miRNAs in man, with each cell type expressing
a distinct repertoire. Increasing evidence has
implicated miRNAs as having causative roles in
a variety of lung diseases and has driven investiga-
tions into their potential as therapeutic targets.
DERIVATION AND FUNCTION
miRNAs are generally derived from precursor
transcripts termed pri-miRNAs. These pri-miRNAs
can either contain a single short miRNA hairpin of
only about 100 nucleotides (nt) in length, or they
can contain multiple miRNA hairpins. A number of
miRNAs, known as miRtrons, are excised from the
introns of protein-coding genes by the cellular
splicing machinery.
The product of miRNA processing is a 19e25 nt
RNA molecule that can be incorporated into a cyto-
plasmic protein complex called RISC, the RNA-
Induced Silencing Complex. Once in the context of
RISC, miRNAs target speciﬁc mRNAs through
WatsoneCrick base pairing which predominately
involves only bases 2e8 of the miRNA, known as
the ‘seed’. A single miRNA may bind to a number of
target transcripts and a single transcript may contain
multiple interaction motifs for a single miRNA or for
different miRNAs. The interaction of a miRNA and
target message culminates in degradation of the
target mRNA, translational repression, or a combi-
nation of both (ﬁgure 1). It is thought that around
60% of all mRNAs within the cell are targeted by
miRNAs, but should just one of those RNAs encode
a critical component of a signal transduction
pathway, then profound downstream inﬂuences
may be triggered by its diminished expression.
TARGET IDENTIFICATION
Despite progress in our understanding of miRNA
biology, the list of validated miRNAemRNA
interactions is not comprehensive. Target identiﬁ-
cation is a major hurdle in miRNA research and is
complicated by the fact that the interaction of
miRNAs with target mRNAs is tolerant of some
degree of mismatch. Where are the regions of
mRNAs that miRNAs target?
Recent unbiased approaches suggest that miRNA
interaction sites may be located throughout the
mRNA transcript. However, historic studies have
shown that interaction motifs tend to be enriched
in the 39 untranslated region (39UTR) of the target
mRNA, a region often involved in the regulation of
mRNA stability. Algorithms commonly used to
predict miRNA targets exploit this bias towards the
39 UTR, possibly leading to the under-investigation
of other regions.
A growing body of literature suggests that there
is disrupted expression of speciﬁc miRNAs either in
lung pathologies themselves or experimental
models thereof. Examples of this are cited for lung
cancer, asthma, ﬁbrosis and chronic obstructive
pulmonary disease (COPD).
Lung cancer
The let-7 miRNA family and the miR-17-92 cluster,
a single transcript which can give rise to seven
distinct miRNAs, have well-deﬁned roles in lung
cancer as tumour suppressors and oncogenes,
respectively. The let-7 family is frequently deleted
in lung cancer and has been shown to regulate RNA
stability of transcripts encoding multiple oncogenes
including Ras1 and cycle regulators such as
cyclinD2. By contrast, miRNAs from the miR-17-92
cluster are overexpressed in small cell lung cancer
and this overexpression is associated with inacti-
vation of function of the retinoblastoma tumour
suppressor.2
Asthma
Mouse models and in vitro studies of human cells
have implicated miRNAs as having causative roles
in asthma. Rodriguez et al have demonstrated that
a total knockout of miR-155 causes the sponta-
neous development of an asthma-like phenotype,
including inﬂammatory inﬁltration into the lung
and airway remodelling.3 TLR4-induced Th2
inﬂammation induces increased expression of miR-
126 and administration of cholesterol-linked single-
stranded inhibitors of miR-126 decreases the levels
of TLR4-induced inﬂammatory inﬁltrate and
airway hyper-responsiveness.4 In addition, treat-
ment of human bronchial smooth muscle cells with
interleukin 13 causes a decrease in the expression of
miR-133a. Artiﬁcial inhibition of miR-133a func-
tion in smooth muscle cells through the use of
antagomirs was shown to increase the expression
of RhoA, a known procontractile protein.5
Fibrosis
Liu et al have described increased miR-21 expression
in both a murine bleomycin-induced ﬁbrosis model
and the lungs of patients with idiopathic pulmo-
nary ﬁbrosis. The authors speculate that miR-21
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may have a role in ﬁbrosis through regulation of an inhibitory
Smad, Smad7.6 miRNA expression proﬁling of human ﬁbrotic
lung biopsies revealed differential expression of 46 miRNAs
compared with cells from controls, including downregulation of
miR-126 and let-7d. Reduction of let-7d expression resulted in
increased collagen deposition and alveolar septal thickening in
vivo and epithelial-mesenchymal transition in vitro.7
COPD
It is well established that smoking is a major risk factor for the
development of COPD. A comparison of the miRNA expression
proﬁle of bronchial epithelial cells from smokers and never-
smokers identiﬁed 28 miRNAs with differential expression and
suggested that miR-218 in particular may play an important role
in modulating epithelial gene expression following exposure to
cigarette smoke.8
CLINICAL RELEVANCE
The increasing evidence for disrupted miRNA expression and
function in disease processes makes them interesting targets
for therapeutic intervention. Applications of miRNA-based
therapy for lung disease are less advanced than for some other
diseases.9 However, promising data are emerging from model
systems. In a recent report it has been shown that the systemic
administration of miRNA mimics to the known tumour
suppressor miRNAs miR-34a and let-7 decreases the in vivo
tumour burden in a mouse model of non-small cell lung cancer
(NSCLC).10
Perhaps a more immediate way of exploiting miRNAs in the
pathogenesis of pulmonary disease is through molecular diag-
nostics, particularly risk stratiﬁcation and outcome prediction.
miR-155 and miR-let7a-2 expression correlate with poor overall
survival in patients with lung adenocarcinoma,11 while a ﬁve-
miRNA signature (miR-137, mir-372, miR-182*, miR-221 and
let-7a) has been shown to correlate with disease-free survival in
patients with NSCLC.12 A further feature of miRNAs is that
they are stable and detectable in blood plasma and serum by
qPCR or array hybridisation. Indeed, Chen et al have recently
shown that the expression proﬁle of serum miRNAs can serve as
an NSCLC ﬁngerprint.13
We are now reaching an exciting juncture in the miRNA ﬁeld
as continuing research into the mechanistic role of miRNAs in
a wide range of diseases is occurring alongside demonstrations
that miRNA are viable targets for both diagnostic screens and
therapeutic intervention.
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Figure 1 Advances in identification of RNA species through deep
sequencing have revealed a number of novel RNA species such as
eRNAs and identified more members of known families such as miRNAs.
miRNAs have been the subject of intensive study and these have now
been shown to anneal to target mRNAs through complementary base
pairing. In most cases this interaction leads to cleavage of the target
mRNA thereby preventing translation. A second mechanism of action
involves blockade of mRNA translation.
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